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A B S T R A C T
Background
Older patients with multiple health problems (multi-morbidity) value being involved in decision-making about their health care. However,
they are less frequently involved than younger patients. To maximise quality of life, day-to-day function, and patient safety, older patients
require support to identify unmet healthcare needs and to prioritise treatment options.
Objectives
To assess the effects of interventions for older patients with multi-morbidity aiming to involve them in decision-making about their health
care during primary care consultations.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; all years to August 2018), in the Cochrane Library; MEDLINE
(OvidSP) (1966 to August 2018); Embase (OvidSP) (1988 to August 2018); PsycINFO (OvidSP) (1806 to August 2018); the Cumulative Index
to Nursing and Allied Health Literature (CINAHL) (Ovid) (1982 to September 2008), then in Ebsco (2009 to August 2018); Centre for Reviews
and Dissemination Databases (Database of Abstracts and Reviews of Effects (DARE)) (all years to August 2018); the Health Technology
Assessment (HTA) Database (all years to August 2018); the Ongoing Reviews Database (all years to August 2018); and Dissertation Abstracts
International (1861 to August 2018).
Selection criteria
We sought randomised controlled trials (RCTs), cluster-RCTs, and quasi-RCTs of interventions to involve patients in decision-making about
their health care versus usual care/control/another intervention, for patients aged 65 years and older with multi-morbidity in primary care.
Data collection and analysis
We used standard Cochrane methodological procedures. Meta-analysis was not possible; therefore we prepared a narrative synthesis.
Main results
We included three studies involving 1879 participants: two RCTs and one cluster-RCT. Interventions consisted of:
· patient workshop and individual coaching using behaviour change techniques;
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· individual patient coaching utilising cognitive-behavioural therapy and motivational interviewing; and
· holistic patient review, multi-disciplinary practitioner training, and organisational change.
No studies reported the primary outcome ‘patient involvement in decision-making’ or the primary adverse outcome ‘less patient involve-
ment as a result of the intervention’.
Comparing interventions (patient workshop and individual coaching, holistic patient review plus practitioner training, and organ-
isational change) to usual care: we are uncertain whether interventions had any effect on patient reports of high self-rated health (risk
ratio (RR) 1.40, 95% confidence interval (CI) 0.36 to 5.49; very low-certainty evidence) or on patient enablement (mean difference (MD)
0.60, 95% CI -9.23 to 10.43; very low-certainty evidence) compared with usual care. Interventions probably had no effect on health-related
quality of life (adjusted difference in means 0.00, 95% CI -0.02 to 0.02; moderate-certainty evidence) or on medication adherence (MD 0.06,
95% CI -0.05 to 0.17; moderate-certainty evidence) but probably improved the number of patients discussing their priorities (adjusted
odds ratio 1.85, 95% CI 1.44 to 2.38; moderate-certainty evidence) and probably increased the number of nurse consultations (incident rate
ratio from adjusted multi-level Poisson model 1.37, 95% CI 1.17 to 1.61; moderate-certainty evidence) compared with usual care. Practi-
tioner outcomes were not measured. Interventions were not reported to adversely affect rates of participant death or anxiety, emergency
department attendance, or hospital admission compared with usual care.
Comparing interventions (patient workshop and coaching, individual patient coaching) to attention-control conditions: we are un-
certain whether interventions affect patient-reported high self-rated health (RR 0.38, 95% CI 0.15 to 1.00, favouring attention control, with
very low-certainty evidence; RR 2.17, 95% CI 0.85 to 5.52, favouring the intervention, with very low-certainty evidence). We are uncertain
whether interventions affect patient enablement and engagement by increasing either patient activation (MD 1.20, 95% CI -8.21 to 10.61;
very low-certainty evidence) or self-efficacy (MD 0.29, 95% CI -0.21 to 0.79; very low-certainty evidence); or whether interventions affect the
number of general practice visits (MD 0.51, 95% CI -0.34 to 1.36; very low-certainty evidence), compared to attention-control conditions.
The intervention may however lead to more patient-reported changes in management of their health conditions (RR 1.82, 95% CI 1.35 to
2.44; low-certainty evidence). Practitioner outcomes were not measured. Interventions were not reported to adversely affect emergency
department attendance nor hospital admission when compared with attention control.
Comparing one form of intervention with another: not measured.
There was 'unclear' risk across studies for performance bias, detection bias, and reporting bias; however, no aspects were 'high' risk.
Evidence was downgraded via GRADE, most often because of 'small sample size' and 'evidence from a single study'.
Authors' conclusions
Limited available evidence does not allow a robust conclusion regarding the objectives of this review. Whilst patient involvement in deci-
sion-making is seen as a key mechanism for improving care, it is rarely examined as an intervention and was not measured by included
studies. Consistency in design, analysis, and evaluation of interventions would enable a greater likelihood of robust conclusions in future
reviews.
P L A I N   L A N G U A G E   S U M M A R Y
Interventions for involving older patients with more than one long-term health problem in decision-making during primary care
consultations
Background
The number of older people with more than one long-term health problem is steadily increasing worldwide. Such individuals can have
complicated healthcare needs. Although they frequently want to be involved in making decisions about their health care, they are less
often involved than younger, healthier people. As a result, they may not be offered the same treatment options.
Review question
We reviewed available evidence about the effects of interventions intended to involve older people with more than one long-term health
problem in decision-making about their health care during primary care consultations.
Study characteristics
We included research published up until August 2018. We found three relevant studies involving 1879 participants. These studies were
reported from three countries. Participants were over 65 years of age with three or more long-term health problems on average. Interven-
tions investigated included:
· patient workshops and individual patient coaching;
· patient coaching including cognitive-behavioural therapy; and
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· whole-person patient review, practitioner training, and organisational changes.
All studies were funded by national research bodies.
Key results
None of the studies reported the main outcome ‘patient involvement in decision-making about their health care’ nor whether there was
less patient involvement as a result of the intervention. Interventions were not found to increase adverse outcomes such as death, anxiety,
emergency department attendance, or hospital admissions..
We are uncertain whether interventions for involving older people with more than one long-term health problem in decision-making about
their health care can improve their self-rated health or healthcare engagement, or make any difference in self-efficacy (one's belief in
one's ability to succeed in specific situations) or in the overall number of general practice visits. We can report that these interventions
probably make little or no difference in patients' quality of life but probably increase the number of patients discussing their priorities, and
are associated with more patient consultations with nurses, when compared to usual care. Interventions may be associated with more
changes in the management of health conditions when considered from the patient’s perspective when compared with a control group.
The quality of the evidence was limited by small studies, and by studies choosing to measure different outcomes, resulting in lack of data
that could be combined in analyses.
Conclusions
Further research in this developing area is required before firm conclusions can be drawn.
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
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Summary of findings for the main comparison.   Interventions for involving older patients with multi-morbidity in decision-making about their
health care compared to usual care for older patients with multi-morbidity
Interventions for involving older patients with multi-morbidity in decision-making about their health care compared to usual care for older patients with mul-
ti-morbidity
Patient or population: older patients with multi-morbidity
Setting: primary care
Intervention: interventions for involving patients in decision-making about their health care (patient workshop and individual coaching, holistic patient review plus mul-
ti-disciplinary practitioner training and organisational change)
Comparison: usual care
Anticipated absolute ef-
fects*(95% CI)
Outcomes
Risk with
usual care
Risk with
interven-
tions for in-
volving pa-
tients in deci-
sion-making
about their
health care
Relative ef-
fect
(95% CI)
№ of partici-
pants
(studies)
Certainty of
the evidence
(GRADE)
Comments
Patient involvement
in decision-making
(primary outcome)
Not measured
  - - - No studies were found that measured patient involve-
ment in decision-making
Study populationHealth status (a)
Patient-reported high
self-rated health at 6
months after baseline
CDC Healthy Days Mea-
sure (CDC 2000): di-
chotomised as low (1
to 3) and high (4 to 5)
143 per 1000 200 per 1000
(51 to 785)
RR 1.40
(0.36 to 5.49)
41
(1 RCT)
⊕⊝⊝⊝
VERY LOWa,b 3
We are uncertain whether interventions for involving pa-
tients in decision-making about their healthcare changes
lead to high self-rated health for older patients with mul-
ti-morbidity
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Health status (b)
Health-related quality
of life at 15 months af-
ter baseline
EQ-5D-5L score (5
questions about mo-
bility, self-care, usu-
al activities, pain and
discomfort, anxiety
and depression, each
measured on a 5-point
scale from no prob-
lems to extreme prob-
lems. Scale 0 to 1. A
higher score indicates
worse quality of life)
(Herdman 2011)
Mean
EQ-5D-5L
score was
0.504
MD 0
(0.02 lower to
0.02 higher)
- 1546
(1 RCT)
⊕⊕⊕⊝
MODERATEc,d
Involving patients in decision-making about their health
care probably makes little or no difference in health-relat-
ed quality of life for older patients with multi-morbidity
Patient enablement
and engagement (a)
Patient Activation
Measure score at 6
months after baseline
(13-item assessment
of knowledge and con-
fidence related to par-
ticipation in care. Re-
sponses on a 4-point
scale are summed and
converted to an ‘Acti-
vation Score’ from 0
to 100). Higher score
shows improvement
(Hibbard 2005)
Mean Patient
Activation
Measure score
was 66.2
MD 0.6 higher
(9.23 lower to
10.43 higher)
- 41
(1 RCT)
⊕⊝⊝⊝
VERY LOWa,b,c
We are uncertain whether interventions for involving pa-
tients in decision-making about their health care improve
patient activation measure scores for older patients with
multi-morbidity
Patient enablement
and engagement (b)
Morisky Medication
Adherence Scale at 15
months after baseline
(8-item yes-no survey.
Range of scores from 0
to 8. Lower scores sug-
Mean Morisky
score was 6.6
MD 0.06 high-
er (0.05 lower
to 0.17 higher
- 1546
(1 RCT)
⊕⊕⊕⊝
MODERATEc,d
Involving older patients with multi-morbidity in deci-
sion-making about their health care probably makes no
difference in Morisky Medication Adherence Scale scores
for older patients with multi-morbidity
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gest non-adherence)
(Morisky 2008)
Study populationPatient evaluation of
care/the intervention
Care related to pa-
tient priorities at 15
months after baseline
(single question adapt-
ed from the NHS Gen-
eral Practice Patient
Survey (Ipsos MORI
2015); 5-point scale di-
chotomised by patient
reports of discussing
their most important
problems ('almost al-
ways' vs 'not at all' +
'rarely' + 'some of the
time')
263 per 1000 398 per 1000
(340 to 460)
OR 1.85
(1.44 to 2.38)
1211
(1 RCT)
⊕⊕⊕⊝
MODERATEc,d
Involving older patients with multi-morbidity in deci-
sion-making about their health care probably improves
the proportion of patients reporting care related to their
priorities
Practitioners' knowl-
edge and skills
Not measured
  - - - No studies were found that looked at practitioners'
knowledge and skills
Study populationResource use and
cost
Number of nurse
consultations at 15
months after baseline
(extracted from pa-
tients’ routine elec-
tronic medical records)
5 per 1000 7 per 1000
(6 to 8)
Rate ratio 1.37
(1.17 to 1.61)
1517
(1 RCT)
⊕⊕⊕⊝
MODERATEc,d
Involving patients in decision-making about their health
care probably increases the number of nurse consulta-
tions for older patients with multi-morbidity
Adverse events**
Less patient involve-
ment
Not measured
  - - - No studies were found that looked at the primary adverse
event of less patient involvement as a result of the inter-
vention
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI). The assumed risk in the comparison group is the mean, or median, risk (as reported in included studies) from the comparison groups. .
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**Salisbury 2018 recorded full details of participant death and reported no differences between intervention and usual care groups and no association between death and
the intervention. Salisbury 2018 reported no difference between intervention and usual care groups in rates of hospital admissions, in accident and emergency department
visits, or in patient anxiety.
CI: confidence interval; EQ-5D-5L: EuroQoL Group Quality of Life Questionnaire based on a five-level scale; NHS: National Health Service; OR: odds ratio; RCT: randomised
controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aUnclear performance bias, detection bias, and reporting bias have the potential to affect the outcome; however, not considered 'serious' risk (certainty not downgraded for
risk of bias).
bSmall sample size (no. of events < 300) (certainty downgraded -2 for imprecision).
cAll results from the same study in a developing evidence base (certainty downgraded -1 for indirectness).
dUnclear performance bias and detection bias have the potential to affect the outcome; however, not considered 'serious' risk (certainty not downgraded for risk of bias).
 
 
Summary of findings 2.   Interventions for involving patients in decision-making about their health care compared to attention-control conditions for
older patients with multi-morbidity
Interventions for involving patients in decision-making about their health care compared to attention-control conditions for older patients with multi-morbidity
Patient or population: older patients with multi-morbidity
Setting: primary care
Intervention: interventions for involving patients in decision-making about their health care (patient workshop and individual coaching, individual patient coaching)
Comparison: attention-control conditions
Anticipated absolute effects* (95% CI)Outcomes
Risk with atten-
tion-control con-
ditions
Risk with inter-
ventions for in-
volving patients in
decision-making
about their health
care
Relative ef-
fect
(95% CI)
№ of partici-
pants
(studies)
Certainty of
the evidence
(GRADE)
Comments
Patient involvement in
decision-making
(primary outcome)
  - - - No studies were found that measured patient
involvement in decision-making
C
o
ch
ra
n
e
L
ib
ra
ry
T
ru
ste
d
 e
v
id
e
n
ce
.
In
fo
rm
e
d
 d
e
cisio
n
s.
B
e
tte
r h
e
a
lth
.
  
C
o
ch
ra
n
e D
a
ta
b
a
se o
f S
ystem
a
tic R
e
vie
w
s
In
te
rv
e
n
tio
n
s fo
r in
v
o
lv
in
g
 o
ld
e
r p
a
tie
n
ts w
ith
 m
u
lti-m
o
rb
id
ity
 in
 d
e
cisio
n
-m
a
k
in
g
 d
u
rin
g
 p
rim
a
ry
 ca
re
 co
n
su
lta
tio
n
s (R
e
v
ie
w
)
C
o
p
yrig
h
t ©
 2019 T
h
e C
o
ch
ra
n
e C
o
lla
b
o
ra
tio
n
. P
u
b
lish
ed
 b
y Jo
h
n
 W
ile
y &
 S
o
n
s, Ltd
.
8
Not measured
Health status
Patient-reported high
self-rated health at 6
months after baseline.
Hochhalter used CDC
Healthy Days Measure
(CDC 2000); Reed used
a similar 5-point Likert
scale developed by the
US National Health and
Nutrition Examination
Survey; each scale was
dichotomised as low (1
to 3) and high (4 to 5)
Higher score shows im-
provement
Hochhalter 2010 reported fewer inter-
vention participants reported high self-
rated health when compared to atten-
tion-control participants at 6 months
(RR 0.38, 95% CI 0.15 to 1.00; P = 0.05).
Conversely, Reed 2018 reported more
intervention participants reported high
self-rated health than attention-control
participants at 6 months (RR 2.17, 95%
CI 0.85 to 5.52; P = 0.11)
Results were not pooled due to high het-
erogeneity between studies and opposite
directions of effect
- 297
(2 RCTs)
⊕⊝⊝⊝
VERY
LOWa,b,c,d
We are uncertain whether involving patients in
decision-making about their health care either
increases or decreases reports of high self-rat-
ed health for older patients with multi-morbid-
ity
Patient enablement
and engagement (a)
Patient activation at 6
months after baseline.
Patient Activation Mea-
sure score (13-item as-
sessment of
knowledge and confi-
dence related to partici-
pation in care. Respons-
es on a 4-point scale are
summed and converted
to an ‘Activation Score’
from 0 to 100) (Hibbard
2005)
Higher score shows im-
provement
Mean Patient Ac-
tivation Measure
score was 65.6
MD 1.2 higher
(8.21 lower to 10.61
higher)
- 43
(1 RCT)
⊕⊝⊝⊝
VERY
LOWa,e,f,g
We are uncertain whether interventions for in-
volving patients in decision-making about their
health care change Patient Activation Measure
scores for older patients with multi-morbidity
Patient enablement
and engagement (b)
Self-efficacy at 6 months
after baseline
Mean self-efficacy
rating was 6.26
MD 0.29 higher
(0.21 lower to 0.79
higher)
- 254
(1 RCT)
⊕⊝⊝⊝
VERY LOWe,f,g
We are uncertain whether interventions for in-
volving patients in decision-making about their
health care either increase or decrease self-effi-
cacy for older patients with multi-morbidity
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(self-efficacy for manag-
ing chronic disease scale
assessed from scores on
6 items rated 1 ‘not at all
confident’ to 10 ‘total-
ly confident’) (Stanford
2018)
Higher score shows im-
provement
Study populationPatient evaluation of
care/the intervention
Patient reports that the
intervention changed
management of his or
her health at 6 months
after baseline (3-point
scale: dichotomised
into 'a great deal' vs
'somewhat' + 'not at all')
(Stanford 2018)
Higher score shows im-
provement
333 per 1000 607 per 1000
(450 to 813)
RR 1.82
(1.35 to 2.44)
231
(1 RCT)
⊕⊕⊝⊝
LOWf,g
Involving older patients with multi-morbidi-
ty in decision-making about their care may in-
crease patient reports of changed management
of their health
Practitioners' knowl-
edge and skills
Not measured
  - - - No studies were found that looked at practi-
tioners' knowledge and skills
Resource use and cost
Number of general
practice visits in the 6
months following base-
line
(patient self-report via
questionnaire)
Mean number
of self-reported
general practice
visits was 4.82
MD 0.51 higher
(0.34 lower to 1.36
higher)
- 254
(1 RCT)
⊕⊝⊝⊝
VERY
LOWf,g,h,i
We are uncertain whether involving patients
in decision-making about their health care
changes the number of general practice visits
reported by older patients with multi-morbidity
Adverse event**
Less patient involve-
ment as a result of the
intervention
  - - - No studies were found that looked at less pa-
tient involvement as a result of the intervention
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0
Not measured
*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). The
assumed risk in the comparison group is the mean risk from the comparison groups in included studies.
**Reed 2018 reported no difference between intervention and usual care groups in numbers of hospital admissions and in numbers of accident and emergency department
visits.
CDC: Centers for Disease Control and Prevention; CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence.
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aUnclear performance bias, detection bias, and reporting bias have the potential to affect the outcome; however, not considered 'serious' risk (certainty not downgraded for
risk of bias).
bHigh heterogeneity with effects in opposite directions (certainty downgraded -1 for inconsistency).
cSmall sample size, no. of events < 300 (certainty downgraded -2 for imprecision).
dResults from two small studies in a developing evidence base (certainty downgraded -1 for indirectness).
eAll results from the same small study in a developing evidence base (certainty downgraded -1 for indirectness).
fSmall sample size, no. of participants < 400 (certainty downgraded -1 for imprecision).
g95% confidence intervals include no effect and may cross the minimally important difference (certainty downgraded -1 for imprecision).
hPatient self-report as opposed to objective measure (certainty downgraded -1 for risk of bias (blinding)).
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B A C K G R O U N D
Description of the condition
Life expectancy is predicted to continue to rise globally (Oep-
pen 2002), and the prevalence of long-term conditions increases
with age (Melzer 2015). The co-existence of two or more chron-
ic (long-term) conditions is termed multi-morbidity (Academy of
Medical Sciences 2018). Quality of care for older patients with mul-
ti-morbidity may be worsening when compared to management
of patients with long-term conditions in general (Higashi 2007;
Steel 2014). Consequences of multi-morbidity include functional
decline, which is associated with poor quality of life, high health-
care utilisation and costs, reduced life expectancy, and a negative
impact on the health of carers for patients with multi-morbidity
(Academy of Medical Sciences 2018; Marengoni 2011).
Our previous work identified that older patients value being in-
volved in decision-making about their health care (Butterworth
2014). However, they are less frequently involved in decision-mak-
ing than younger patients (van den Brink-Muinen 2006). Evidence
suggests associated health inequalities including discrepancies in
rates of referral and requests for investigation among older people
with multi-morbidity (Drennan 2007; McBride 2010; Tate 2010).
The importance of involving older patients with multi-morbidity
in decision-making about their care when seeking to identify un-
met healthcare needs has been acknowledged (Couët 2015; De-
partment of Health and Social Care (UK) 2001; Homa 2015; IliGe
2004; Noël 2007). Older patients need support in prioritising and ra-
tionalising treatment options to maximise quality of life and day-to-
day function (Kiesler 2006; Peters 1994). Recent research suggests
that supporting older patients with multi-morbidity in communi-
cating their needs and concerns to healthcare providers could re-
duce risks to patient safety (Hays 2017).
‘Old age' refers to nearing the end of the natural human life cycle.
Whilst the widely accepted definition of an older person in western-
ised countries encompasses individuals aged 65 years and older,
with the rise in life expectancy this age category is widening (Dong
2016; Oeppen 2002). Therefore, there may be differing healthcare
requirements across the widening 'older' age group that must be
considered by future research and, in particular, by intervention
studies designed to support the needs of this patient group. Many
currently available interventions appear outdated in their assess-
ments of this population with regard to their wish for involvement
in decision-making about their individual healthcare needs.
Description of the intervention
This Cochrane Review assesses the effects of interventions for old-
er patients with multi-morbidity with the aim of involving them in
decision-making about their health care during primary care con-
sultations. We searched the literature for systematic reviews of in-
terventions with a related aim, seeking to inform the description
of interventions to be included in this review (Kinnersley 2008; Lé-
garé 2018; Smith 2016; Wetzels 2007). Our description of the com-
ponents of patient involvement in decision-making is also influ-
enced by the components of patient-centred care as suggested by
Wensing 2003.
Interventions may be delivered before or during a single consulta-
tion, or they may span multiple consultations. Studies may encom-
pass one or any combination of three types of interventions centred
around a consultation with a primary care practitioner.
• Patient-focused (e.g. written or online decision-support tools
such as ‘option grids’ that can be completed with a practition-
er during a consultation or completed by the patient outside of
and before the consultation).
• Practitioner-focused (e.g. training in communication skills for
use during a consultation).
• Related to organisational change (e.g. increased length of the
consultation).
Interventions may be delivered, as well as received, by primary care
practitioners, or they may be delivered by external clinicians or re-
searchers or by administration staG. They may be facilitated by a
patient's carer (a family member or friend, or a paid helper who reg-
ularly looks after the patient), who may or may not be present dur-
ing a consultation.
We considered all interventions designed to facilitate involvement
of patients with multi-morbidity in decision-making about their
health care during primary care consultations.
How the intervention might work
Within the patient-practitioner consultation, patient involvement
in decision-making refers to activities carried out by:
• a practitioner seeking to facilitate a patient's active engage-
ment in decision-making within the consultation (including us-
ing ‘shared decision-making'-related communication skills and/
or encouraging patient autonomy and empowering self-man-
agement and/or changing the way that information is delivered
to meet patient preferences); and
• patients seeking to increase their own involvement in deci-
sion-making during the consultation (including expressing a
preference for involvement, using written decision-making sup-
port tools, and taking ownership of patient-held records).
In addition, changes can be made to the organisation of care, so
that healthcare services more comprehensively address patients’
needs and preferences, potentially enabling patient involvement
in decision-making about their health care. Therefore, a third ap-
proach to patient involvement in decision-making is directed to-
wards improving the quality of healthcare delivery within the con-
sultation, and might include longer consultations (to allow time for
patient involvement in decision-making to take place, for example)
or organisational change, with system improvements to facilitate
continuity of care with an individual practitioner (Wensing 2003).
Shared decision-making has been defined as "an approach where
clinicians and patients share the best available evidence when
faced with the task of making decisions, and where patients
are supported to consider options, to achieve informed prefer-
ences" (Elwyn 2010). Patient involvement in decision-making dur-
ing healthcare consultations has long been identified and remains
a priority feature of high-quality patient-centred care (Coulter 2011;
WHO 1994; WHO 2018). Delivering such care is associated with
improved outcomes for patients, doctors, and healthcare teams.
These include patient adherence with treatment advice, satisfac-
tion with health care, and trust in the doctor (Croker 2013; Flocke
2013; Loh 2007; Ommen 2011).
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
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The primary care practitioner's role in shared decision-making in-
volves seeking the patient's implicit or explicit involvement in the
decision-making process; exploring the patient’s ideas, fears, and
expectations about the problem and possible treatments; provid-
ing a balanced view in the discussion of healthcare options; con-
veying tailor-made healthcare information; checking the patient’s
understanding of the information and his or her reactions to it; ask-
ing about the patient’s decision-making role preference; making,
discussing, or deferring decisions with the patient; and arranging
for appropriate follow-up (Elwyn 2000).
Elywyn's refined 'three-talk model' outlines conversational steps in
which the practitioner provides support when introducing options,
followed by strategies to compare and discuss trade-oGs in the de-
cision to be made before a process of deliberation takes place that
is based on the patient's informed preferences (Elwyn 2017).
Whilst many studies have reported patients' positive views of the
processes of involvement in decision-making about their health
care, some have suggested that older patients may not value feel-
ing involved in this way (Levinson 2005). Our previous work used
qualitative methods to examine these apparent conflicts (Butter-
worth 2014). We found that, in general, older patients do value feel-
ing involved in the decision-making process, but it is important to
recognise that patient perceptions vary regarding what it means to
be 'involved' (Berkelmans 2010; Kiesler 2006). For example, some
participants did not report valuing every element of a shared de-
cision-making approach identified in the literature as being of im-
portance (Elwyn 2000). We therefore considered studies evaluating
all interventions designed to facilitate involvement of patients with
multi-morbidity in decision-making about their care, to understand
the effects of these interventions for older patients living with mul-
ti-morbidity without solely focusing on a shared decision-making
approach. We also considered studies of interventions designed to
facilitate patient involvement in decision-making that were not de-
signed for but were investigated in our population of interest.
Patients' perceptions of involvement in decision-making about
their health care are considered important in predicting outcomes
(Saba 2006). For example, there are positive associations between
patients’ trust in a general practitioner (GP) and their perceptions
of having been involved in decision-making. The strength of this
association increases with increasing patient age (Croker 2013). A
brief review of the current literature suggests that it is difficult to
draw firm conclusions regarding which types of interventions might
most effectively facilitate the adoption of patient involvement in
decision-making by primary care practitioners (Légaré 2018).
A 2007 Cochrane Review considered interventions to improve old-
er patients’ involvement in primary care consultations, including
their involvement in decision-making about their health care (Wet-
zels 2007); however, it did not address the issue of multi-morbidi-
ty. At that time, the review authors reported on three intervention
studies and concluded that available evidence was sparse. Howev-
er, that review is now dated, and new research is available. This
systematic review of new evidence aims to provide greater clarity
regarding which interventions may best support the involvement
of older patients with multi-morbidity in decision-making about
their care, to achieve positive outcomes for patients, doctors, and
healthcare teams, as outlined above.
Why it is important to do this review
There are concerns that current delivery of good-quality care is not
meeting the needs of older patients, who often experience mul-
ti-morbidity (Salisbury 2012; Steel 2014). Older patients account for
a large percentage of spending in primary care: 37% in UK (RCGP
2013). Such patients consult more frequently (Hobbs 2016), creat-
ing a substantial component of the primary care workload. The bur-
den on primary care associated with this vulnerable patient group
can be expected to increase as the prevalence of multi-morbidity in
older age groups is predicted to rise (from 45.7% in 2015, to 52.8%
in 2035, for people aged 65 to 74 years) (Kingston 2018). It is only re-
cently that the benefits for older patients with multi-morbidity de-
rived from participating in decision-making about their health care
have been acknowledged.
The National Institute for Health and Care Excellence (NICE) in UK
has published guidelines for the clinical assessment and manage-
ment of patients with multi-morbidity (NICE 2016). These guide-
lines recommend that patients with multi-morbidity should be in-
volved in decision-making about their health care. However, guide-
line authors have provided little instruction on how this should be
achieved. Our review is warranted to provide evidence-based guid-
ance to policy makers, researchers, and commissioners on how
they can direct funding towards good-quality interventions target-
ing involvement of older patients in decision-making about their
health care, and how they can provide practical guidance to clini-
cians who adopt these interventions.
We identified six previous reviews by conducting a brief literature
search and by seeking the advice of content experts (Coulter 2015;
Dawmena 2012; Kinnersley 2008; Légaré 2018; Rolfe 2014; Smith
2016). We discuss the similarities and differences between these re-
views and our review by using the Donabedian structure/process/
outcomes model (Donabedian 1988); we also discuss why our re-
view is needed to fill an important gap in the current literature (see
Table 1).
Previous reviews have examined interventions specifically target-
ing shared decision-making, and largely focusing on other patient
populations. However, we feel it is important to carry out a review
of all interventions developed with the aim of facilitating the in-
volvement of older patients with multi-morbidity in decision-mak-
ing about their care. Therefore, our review will have a broader
scope than past reviews in terms of the interventions, and a nar-
rower scope in terms of the population.
We are not aware of any significant overlap with other Cochrane or
non-Cochrane Reviews, either published or in progress.
Our review will inform the development of an intervention aimed at
facilitating the involvement of older patients with multi-morbidity
in decision-making about their health care when visiting a prima-
ry care physician. Feasibility testing will then inform the planning
and design of a future definitive randomised controlled trial of the
intervention. We hope that other researchers will use this review to
similarly inform their work to support this growing and vulnerable
patient population.
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
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O B J E C T I V E S
To assess the effects of interventions for older patients with mul-
ti-morbidity aiming to involve them in decision-making about their
health care during primary care consultations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included individually randomised controlled trials (RCTs), clus-
ter-RCTs, and quasi-RCTs (trials in which randomisation is attempt-
ed but is subject to potential manipulation, such as allocating par-
ticipants by day of the week, date of birth, or sequence of entry into
a trial). We anticipated that few high-quality RCTs would have been
conducted on this topic, as many studies specifically exclude older
patients or those with more than one health problem.
Types of participants
The patient population consisted of older patients (65 years of age
and older) with multi-morbidity (more than one long-term health
problem) and included their carers. However, we anticipated that
searching for studies with such specific participant inclusion crite-
ria might limit our findings. We included studies in which 100% of
patients had multi-morbidity when we could determine this infor-
mation from the trial report or from author contact, or when strati-
fication of study findings enabled data on patients with multi-mor-
bidity to be separately extracted and analysed. We planned to in-
clude studies in which 75% or more of the patient population was
65 years of age or older.
Like most researchers conducting studies in developed world coun-
tries, we have accepted the chronological age of 65 years and older
as the definition of an older person. However, we recognise that,
like many westernised concepts, this does not adapt well to circum-
stances in developing countries.
We included any study in which the study authors’ definition of mul-
ti-morbidity incorporates our own. Our definition of ‘more than one
long-term health problem' therefore encompasses studies in which
multi-morbidity is defined as ‘three or more chronic conditions', for
example.
We did not specify a minimum length of time for long-term condi-
tions, examples of which include angina or heart problems; arthritis
or joint problems; asthma or chest problems; blindness or severe
visual impairment; cancer in the last five years; deafness or severe
hearing impairment; diabetes; epilepsy; high blood pressure; kid-
ney or liver disease; back problems; mental health problems; and
neurological problems. We adapted this list from the English Na-
tional General Practice Patient Survey (GPPS) (Ipsos MORI 2015).
When dyads of conditions occurred within the same category of the
GPPS (e.g. anxiety, depression), we counted these as only one con-
dition (e.g. mental health problems).
We excluded studies that did not measure specific long-term con-
ditions but instead reported health ‘domains’ or ‘problems’. We
recognise that polypharmacy does not always equate to multi-mor-
bidity, and therefore we did not consider a study population pre-
senting with polypharmacy alone as sufficient for inclusion in the
review.
We defined primary care as "first-contact, continuous, comprehen-
sive, and coordinated care provided to populations undifferentiat-
ed by gender, disease, or organ system" (Starfield 1994). We includ-
ed all interventions involving patients, their carers, primary care
practitioners, and primary care administration staG (including re-
ceptionists) that were delivered within primary care with the aim
of improving patient involvement within a primary care consulta-
tion. This included interventions delivered in the patient's home
but initiated by the primary healthcare team. It also included inter-
ventions initiated by the research team but delivered in the context
of primary care. We included patients in care or in nursing homes.
We included carer participation because this is likely to be of rel-
evance to consultations involving vulnerable, older patients with
multi-morbidity. We recognised that interventions may have mul-
tiple components that it would be important to capture. Using ad-
ministration staG to ensure organisational change within the prac-
tice may be one of these elements. We did not exclude patient par-
ticipants based on whether they had public or private insurance.
We included studies involving interventions delivered by all types
of practitioners working within primary care (e.g. doctors, nurses,
physiotherapists, occupational therapists, mental health workers,
pharmacists). We excluded dentists because our focus was around
general medical practice. We included interventions delivered by
non-clinical researchers or teachers/trainers to patients or practi-
tioners, for example, training in communication skills.
Interventions could be directed at patients, primary care practi-
tioners, or both. Interventions could be delivered to patients by pri-
mary care practitioners, and in some situations, practitioners could
receive one element of an intervention (e.g. training in communi-
cation skills) and deliver another element (e.g. written support tool
used during a consultation).
Alternatively, or additionally, interventions could involve organisa-
tional change within the practice, for example, longer consultation
times.
We excluded interventions delivered by secondary care practition-
ers to their patients and interventions delivered to patients who
had been recruited via secondary care because we consider the pri-
mary care setting to include healthcare practitioners and adminis-
trative staG working within the patient’s general practice surgery;
in the wider community, for example, community pharmacies and
community support groups; and in the patient’s home. We exclud-
ed consultations in acute care settings (e.g. accident and emer-
gency department settings, out of hours services) because we are
interested in first-contact, continuous, comprehensive, and co-or-
dinated care provided by a primary care practitioner, as described
by Starfield 1994. We excluded studies in which only part of the in-
tervention was delivered or facilitated via primary care, unless it
was possible to differentiate findings according to intervention set-
ting.
Types of interventions
There may be different types of interventions with the common aim
of involving patients in decision-making about their health care.
We expected to find face-to-face interventions for patients and/or
practitioners, written or online information sheets with prompts for
use before or during consultations, and some elements of organi-
sational change within the primary care environment.
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
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As we are interested in all interventions that facilitate patient in-
volvement in decision-making about their health care, this is not
limited to a shared decision-making approach. Therefore, we did
not specify that the intervention needed to meet a certain num-
ber of shared decision-making elements (Elwyn 2000; Elwyn 2017).
Equally, we recognise that shared decision-making usually requires
shared equipoise informed by the preferences and values of the
patient and the practitioner. With a motivational interviewing ap-
proach, the goals related to a decision have usually already been
set by the practitioner. We did not exclude interventions whereby
the goal had already been set by the practitioner unless the aim
of the intervention was to persuade the patient to meet that goal.
We also did not exclude interventions that utilised a predetermined
patient goal.
Decisions around care at the end of life are important for this pa-
tient group, and studies were not excluded on the basis of this sub-
ject area when decisions were being made regarding immediate
and specific management options. However, we did exclude inter-
ventions related to advanced directives, as planning for the future
can often involve making hypothetical decisions. These sorts of de-
cisions are different from those underpinned by a patient’s current
priorities and immediate healthcare needs. We planned to exclude
studies in which decision-making about any type of hypothetical
issues had taken place.
We included interventions if they addressed only a decision-mak-
ing process surrounding a single long-term condition in a patient
with multi-morbidity, as long as the aims of the study were to facil-
itate patient involvement in decision-making about their care. We
included studies that investigated interventions with older patients
with multi-morbidity, even if the intervention was not originally de-
signed for this patient population.
We included both patient-focused and practitioner-focused inter-
ventions taking place before or during consultations. These could
relate to single-patient encounters with a practitioner or may relate
more broadly to patients’ use of primary health care. Interventions
could focus on using healthcare information resources, on prepar-
ing patients for patient-practitioner contacts, or on training practi-
tioners in consultation skills.
Patient-focused interventions could include patient decision aids:
pre-consultation mail-outs advising patients how to actively seek
involvement in decision-making about their care during a consul-
tation; ‘option grids’ and ‘risk diagrams’ delivered by practition-
ers to aid involvement in decision-making regarding treatments or
regarding investigations during consultations; hand-held patient
care plans with documentation of shared decisions made between
patient and practitioner to aid in subsequent follow-up discussions
about these decisions; conversation aids (Montori 2017); and pa-
tient agenda cards (Hamilton 2006).
Practitioner-focused interventions could involve training in pa-
tient-centred communication skills and in interventions that raise
practitioner awareness of the potential benefits of involvement in
decision-making for this patient group.
Studies of interventions encompassing organisational change
could include longer consultations for older patients with mul-
ti-morbidity to allow time for effective involvement in deci-
sion-making, or allowing a third person (e.g. a carer) to be present
within the consultation to act as a facilitator of the patient’s in-
volvement. Interventions focused solely on aspects of organisa-
tional change, for example, improving appointment availability,
waiting lists, and consultation duration, were included only when
the intervention explicitly aimed to facilitate the involvement of
older patients with multi-morbidity in decision-making about their
health care. Chrischilles 2014 is an example of a study examining
an organisational change intervention (providing personal health
records to patients) that does not explicitly involve patients in de-
cision-making and so was judged as ineligible for this review.
Interventions delivered by clinician-researchers could include
leaflets for patients or training for practitioners. Interventions de-
livered by practitioners to patients during consultations could be
based on use of patient-centred communication skills. Interven-
tions delivered by administration staG to patients could include
mail-outs of information sheets and decision aids or distribution of
consultation prompts in the waiting room.
We included studies that compared the intervention versus usual
care or versus no intervention. We included studies with multiple
arms evaluating the effectiveness of one form of intervention ver-
sus another, or evaluating the effectiveness of more than one inter-
vention by comparing each with usual care.
We expected to identify studies assessing outcomes from patient
and/or practitioner and/or observer perspectives.
We used the Template for Intervention Description and Replication
(TIDieR) checklist to guide our description of intervention compo-
nents (Hoffmann 2014).
Types of outcome measures
The main outcome categories for the ‘Summary of findings' ta-
ble were (1) evidence of patient involvement in decision-making;
(2) health status; (3) patient engagement and enablement; (4) pa-
tient evaluation of care or of the intervention; (5) practitioners’
knowledge and skills; (6) resource use and cost; and (7) primary
adverse outcome (patient, practitioner, or observer perceptions of
less patient involvement in decision-making than before the inter-
vention).
We used the Institute for Health Care Improvement Triple Aim (im-
proving the patient experience of care, improving the health of pop-
ulations, and reducing the per capita cost of health care) to guide
our selection of secondary outcomes (Berwick 2008).
Primary outcomes
Evidence of patient involvement in decision-making during the
consultation from patient and/or practitioner and/or observer
perspectives
Elwyn 2017 proposes that a sequence of skills should be demon-
strated by the practitioner to involve the patient in the deci-
sion-making process. These skills can be measured by a variety of
scales, including by an observer using the OPTION scale (Barr 2015),
or by capturing patient perceptions of involvement (Barr 2014).
Many measures of shared decision-making are available in the lit-
erature (Gärtner 2018).
Simple rating scales, such as those used in the General Practice Pa-
tient Survey (GPPS) in England (Ipsos MORI 2015), can be used to
measure patient and practitioner perceptions, including whether
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patient involvement in decision-making about their health care
took place during a primary care consultation.
Secondary outcomes
Patient and carer outcomes
• Health status: physical health status including clinical outcomes
(physiological measures) and other patient-reported physical
health outcomes (from patient-reported outcome measures);
psychological and psychosocial health status including patient
quality of life, social behaviour, and life satisfaction (from short-
form health surveys such as the World Health Organization
(WHO) quality of life instrument (WHO 2012))
• Treatment burden: medication burden (polypharmacy, co-or-
dinating medication, obtaining prescriptions, using devices),
prescribed lifestyle changes (diet, exercise, smoking, alcohol),
self-monitoring, impact on relationships (family/friends/car-
ers), treatment burden associated with multi-morbidity
• Patient enablement and engagement: health behaviours includ-
ing adherence to treatment plans (from practice databases and
patient survey data), patient-initiated lifestyle changes (diet,
exercise, smoking, alcohol), and knowledge and skills acquisi-
tion for patients including information access, knowledge about
diseases/conditions, knowledge about treatments and risks,
health beliefs, patient enablement for self-care (Howie 1998),
symptom control skills, health-enhancing lifestyle measures
• Patient evaluation of care/the intervention: patient satisfaction
with practitioners and care procedures; trust in the practition-
er; perceptions of practitioner behaviours (knowledge, skills,
empathy, attitudes regarding patient involvement); complaints.
Tools could include the Patient Perceptions of Patient-Centred-
ness (PPPC) instrument (Stewart 2000), as well as the General
Practice Patient Survey (Croker 2013; Ipsos MORI 2015)
• Carer support: patient perceptions or ratings of carer support
• Carer evaluation of care: ratings of satisfaction with the en-
counter
Practitioner outcomes
• Knowledge and skills: knowledge of the potential benefits of
patient involvement in the decision-making process; compe-
tence in patient-centred communication skills (e.g. shared deci-
sion-making skills) (as assessed by the OPTION scale (Barr 2015),
or a similar tool)
• Attitudes (towards the intervention and compliance with it)
• Practitioner satisfaction with the intervention
Health service use and related outcomes
• Resource use and cost: length of consultation, frequency of at-
tendance, types of appointments, cost implications of rates of
referral and investigation, cost of care to the patient, accident
and emergency department attendance, hospital admissions
• Quality of care: measured via condition- or drug-specific
processes, or through patient-centred reports of experiences of
care (Valderas 2019)
Adverse outcomes
• Patient, practitioner, or observer perceptions of less patient in-
volvement in decision-making than before the intervention (pri-
mary adverse outcome); adverse effects of medications; inap-
propriate frequency of appointment attendance (in excess or
did not attend); unwarranted treatments/procedures; increase
in hospital admissions and accident and emergency depart-
ment attendances; increased anxiety in patients due to the in-
tervention process; stress among patients due to receiving infor-
mation; increased practitioner anxiety/stress from the interven-
tion; complaints
At the protocol stage, we were not able to predict every secondary
outcome reported by included studies. However, we selected a pri-
mary outcome, a main adverse outcome, and pre-specified sec-
ondary outcome categories for use at the review stage. We applied
the categorisation process to narrative synthesis of outcomes and
to selection of outcomes for reporting in the ‘Summary of findings'
table.
Two review authors independently categorised the outcomes re-
ported in each included study using the review’s outcome cate-
gories. We planned to resolve any differences in categorisation by
involving a third review author; however, this was not required. We
found that in some cases, we assigned more than one outcome to
each outcome category per study. In this scenario, we did the fol-
lowing.
• Selected the primary outcome as reported by study authors in
published papers to date.
• When no primary outcome was identified, selected the outcome
specified in the sample size calculation.
• If there were no sample size calculations, selected the outcome
that appeared to relate most closely to the primary outcome of
the review.
• When outcomes did not directly relate to the primary outcome,
selected the patient-reported measure, or if there was no pa-
tient-reported measure, selected the measure most relevant to
primary care.
• If all of the above were not appropriate, ranked the effect es-
timates and selected the outcome with the median effect esti-
mate.
It was not appropriate to define, in advance, the timing of outcome
assessment; however we defined this to include assessment at
baseline (immediately after intervention delivery), at medium-term
follow-up (e.g. months), or at long-term follow-up (e.g. years).
Search methods for identification of studies
Electronic searches
We searched the following electronic databases.
• Cochrane Central Register of Controlled Trials (CENTRAL; the
latest issue), in the Cochrane Library (search date 01/08/2018).
• MEDLINE (OvidSP) (1966 to present) (search date 12/08/2018).
• Embase (OvidSP) (1988 to present) (search date 12/08/2018).
• PsycINFO (OvidSP) (1806 to present) (search date 12/08/2018).
• Cumulative Index to Nursing and Allied Health Literature (CI-
NAHL) (Ovid) (1982 to September 2008), then in Ebsco when
no longer indexed by Ovid (2009 to present) (search date
12/08/2018).
• Centre for Reviews and Dissemination Databases (Database
of Abstracts and Reviews of Effects (DARE)) (search date
12/08/2018).
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
15
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
• Health Technology Assessment (HTA) Database (search date
12/08/2018).
• Ongoing Reviews Database (search date 12/08/2018).
• Dissertation Abstracts International (1861 to present) (search
date 12/08/2018).
We present detailed search strategies in Appendix 1 through Appen-
dix 6.
We applied no language or date restrictions.
Searching other resources
We sought additional studies by searching the reference lists of rel-
evant trials and reviews identified. In addition, we examined our
personal literature collections to identify relevant studies. We con-
tacted experts in the field and authors of included studies for ad-
vice as to other known relevant studies. We also searched online
trial registers (WHO International Clinical Trials Registry Platform
(search date 13/08/2018); National Institutes of Health (search date
13/08/2018); ClinicalTrials.gov (search date 15/08/2018)) for ongo-
ing and recently completed studies.
As this is an intervention review, we ran the Endnote Library of all
references through the Cochrane RCT Classifier. Those that were as-
sessed as having a 10 or higher probability out of 100 of being an
RCT were screened first, followed by those of a lower probability.
Data collection and analysis
We followed the methods set out in our protocol and documented
any discrepancies in the Differences between protocol and review
section.
Selection of studies
Two review authors independently screened all titles and abstracts
identified by searches to determine which met the inclusion crite-
ria. We retrieved the full-text articles identified as potentially rel-
evant by at least one review author. Two review authors indepen-
dently screened full-text articles for inclusion or exclusion. We re-
solved discrepancies during title and abstract screening and during
full-text screening by discussion, and by consultation with a third
review author, if necessary, to reach consensus. We listed all poten-
tially relevant papers excluded from the review at this stage as ex-
cluded studies, with reasons provided in the Characteristics of ex-
cluded studies table. We provided citation details and any available
information about the single ongoing study identified. We planned
to collate and report details of duplicate publications, so that each
study (rather than each report) is the unit of interest in the review;
however, this scenario did not arise. We reported the screening and
selection process in a PRISMA flow chart (Figure 1) (Liberati 2009).
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Figure 1.   PRISMA flow diagram.
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Data extraction and management
Two review authors began by independently extracting data from
included studies using an agreed data extraction template. Any
discrepancies were resolved by discussion until consensus was
reached, or through consultation with a third review author when
necessary. We developed and piloted a data extraction form using
the Cochrane Consumers and Communication data extraction tem-
plate.
We extracted data for the following items: study details (aim of
intervention; study design, including type of intervention (practi-
tioner/patient-focused), description of comparison group, recruit-
ment and retention, randomisation, blinding), description of par-
ticipants (country, setting, age, gender, ethnicity, socioeconomic
status, number of long-term conditions, frailty, mobility, receipt
of carer support, communication vulnerability (e.g. health liter-
acy, sensory impairment, cognitive impairment, local language
proficiency)), exclusions, definition of multi-morbidity used in the
study (whether numbers of long-term health problems were list-
ed and counted and types and numbers recorded), types of in-
terventions (patient-/practitioner-/organisation-focused; timing of
intervention delivery; whether the intervention involved a single
episode of care vs multiple episodes), and outcomes (timing of out-
come assessment, primary and secondary outcomes). We adapted
the TIDieR checklist to describe the intervention components (Hoff-
mann 2014).
The Characteristics of included studies table provides more details
of extracted data. Outcome data and results of studies were also
extracted from included studies.
One review author entered all extracted data into Review Manag-
er 5 (Review Manager 2014), and another review author, working
independently, checked them for accuracy against the data extrac-
tion sheets.
Assessment of risk of bias in included studies
We assessed and reported on the methodological risk of bias of
included studies in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011), as well as the
guidelines of the Cochrane Consumers and Communication Review
Group (Ryan 2013), which recommend explicit reporting of the fol-
lowing individual elements for RCTs: random sequence generation;
allocation sequence concealment; blinding (participants, person-
nel); blinding (outcome assessment); completeness of outcome da-
ta; selective outcome reporting; and other sources of bias. Aside
from 'selective recruitment of cluster participants' (assessed for
cluster-RCTs only), we did not pre-specify any sources of bias for the
'other sources of bias' domain. Therefore, if no new sources of bias
were identified, studies were rated at low risk for this domain. We
considered blinding separately for different outcomes, as appropri-
ate. We judged each item as being at high, low, or unclear risk of
bias, as set out in the criteria provided by Higgins 2011; extracted
a quote from the study report; and provided a justification for our
judgement for each item in the ‘Risk of bias’ table.
Studies were deemed to be at highest risk of bias if they were scored
as at high or unclear risk for the sequence generation or allocation
concealment domain, based on growing empirical evidence that
these factors are particularly important potential sources of bias
(Higgins 2011).
In all cases, two review authors independently assessed the risk of
bias of included studies, with any disagreements resolved by dis-
cussion to reach consensus. We contacted study authors for addi-
tional information about the included studies, or for clarification of
study methods as required. We incorporated results of the ‘Risk of
bias’ assessment into the review through standard tables, system-
atic narrative description, and commentary about each of the ele-
ments, leading to an overall assessment of the risk of bias of includ-
ed studies and a judgement about the internal validity of review re-
sults.
We planned to assess and report quasi-RCTs as being at high risk of
bias for the random sequence generation item of the ‘Risk of bias’
tool. We assessed and reported cluster-RCTs on the risk of bias as-
sociated with an additional domain: selective recruitment of clus-
ter participants (described in Ryan 2013). We did not plan to restrict
any meta-analysis to only low risk of bias studies but planned in-
stead to explore the effects of risk of bias through sensitivity analy-
sis.
Measures of treatment e:ect
For dichotomous outcomes, we analysed data based on the num-
bers of events and the numbers of people assessed in the interven-
tion and comparison groups. We compared risks, odds and rates of
events, reporting risk ratios, odds ratios, and rate ratios with 95%
confidence intervals (CIs). For continuous measures, we analysed
data based on mean, standard deviation (SD), and number of peo-
ple assessed for both intervention and comparison groups to cal-
culate mean difference (MD) and 95% CI. We planned, when the
MD was reported without individual group data, to use this to re-
port study results. For the included cluster-RCT, data were skewed;
therefore we presented data based on median and interquartile
range as reported by study authors, and used the generic inverse
variance method, with data adjusted to account for the intracluster
correlation coefficient (ICC), to present the findings. If more than
one study measured the same outcome using different tools, we
had planned to calculate the standardised mean difference (SMD)
and the 95% CI using the generic inverse variance method in Review
Manager 5 (Review Manager 2014); however, this scenario did not
occur.
Unit of analysis issues
We checked included cluster-RCTs for unit of analysis errors. If er-
rors had been found, and sufficient information was available, we
planned to re-analyse the data using the appropriate unit of analy-
sis, by taking account of the ICC. We planned to obtain estimates
of the ICC by contacting authors of included studies, or to impute
them using estimates from external sources. When it was not pos-
sible to obtain sufficient information to re-analyse the data, we
planned to report effect estimates and to annotate ‘unit of analysis
errors’. However we found no unit of analysis errors in the included
cluster-RCT.
Dealing with missing data
We contacted study authors to request missing data (participant,
outcome, or summary data). For participant data, when possible,
we conducted analysis on an intention-to-treat (ITT) basis; other-
wise we analysed data as reported. We reported on levels of loss to
follow-up and assessed this as a source of potential bias.
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For missing outcome or summary data, we planned to impute miss-
ing data and to report any assumptions in the review; however,
there were no instances when this was possible. We planned to in-
vestigate, through sensitivity analyses, the effects of any imputed
data on pooled effect estimates; however, this was not possible due
to the small number of included studies.
Assessment of heterogeneity
We considered whether studies were similar enough (by compar-
ing similarities across interventions and patient populations) to al-
low pooling of data related to the one common outcome of inter-
est across two studies, using meta-analysis. No statistical pooling
was possible. We planned to assess the degree of heterogeneity by
visually inspecting forest plots and by examining the Chi2 test for
heterogeneity. We planned to quantify heterogeneity using the I2
statistic. We planned to consider an I2 value of 50% or more to rep-
resent substantial levels of heterogeneity, and we interpreted this
value in light of the size and direction of effects and the strength
of the evidence for heterogeneity, based on the P value from the
Chi2 test (Higgins 2011). When heterogeneity was found in pooled
effect estimates, we planned to explore possible reasons for vari-
ability using narrative analysis.
We determined that studies were not similar enough to allow pool-
ing of outcome data using meta-analysis due to clinical, method-
ological, and statistical heterogeneity and reporting of dissimilar
outcome measures in relation to our outcome categories. We there-
fore did not report pooled results from meta-analysis but instead
used a narrative approach to data synthesis. We attempted to ex-
plore possible clinical or methodological reasons for variation in
the data by grouping studies that were similar in terms of popula-
tions, intervention features, or methodological features to explore
differences in intervention effects.
Assessment of reporting biases
We assessed the likelihood of reporting bias qualitatively based on
the characteristics of included studies (e.g. when only small stud-
ies that indicate positive findings were included in the review), and
when information that we obtained by contacting experts and au-
thors of studies suggested that there were relevant unpublished
studies.
Insufficient studies were included in the review to allow construc-
tion of a funnel plot and formal testing of asymmetry, which may
indicate publication bias. Should enough studies be included in fu-
ture updates of the review, we will plan to undertake these analy-
ses, with the choice of test based on advice in Higgins 2011.
Data synthesis
We decided whether to meta-analyse data based on whether the
interventions in included trials were similar enough in terms of par-
ticipants, settings, interventions, comparisons, and outcome mea-
sures to ensure meaningful conclusions from a statistically pooled
result. Due to expected variability in the populations and interven-
tions of our few included studies, we planned to use a random-ef-
fects model for meta-analysis. Random-effects models are partic-
ularly flawed when there are only a few studies, as there are not
enough data points to calculate tau2 (the estimate of the variance
of the distribution of effects between studies); therefore, the review
authors decided that it was not appropriate to use meta-analysis
for the only common outcome measure, which was reported by on-
ly two studies.
We were unable to consider pooling any other outcome data sta-
tistically using meta-analysis due to variability in terms of the out-
come measures reported by included studies. We therefore con-
ducted a narrative synthesis of results. We presented the major out-
comes and results organised by pre-specified outcome categories
within the main comparisons of the review.
• Intervention versus control.
• Intervention versus usual care.
• One form of intervention versus another form of intervention.
If studies compared more than one intervention, we had planned
to compare each separately to no intervention/control, and to one
another; however, no included studies compared more than one
intervention.
Narrative synthesis was used to explore the relationships between
study findings. A general framework was followed, as recommend-
ed by Popay 2006: review authors first considered the theory be-
hind the included interventions (as reported by study authors) and
compared the similarities and differences between the theory ap-
plied by included studies, using knowledge of the field to develop a
conceptual model of the theory underlying the included interven-
tions. Review authors then conducted a preliminary synthesis of
study findings, explored relationships in the data and referred back
to the theoretical model when interpreting these, and finally con-
sidered the robustness of the synthesis.
Subgroup analysis and investigation of heterogeneity
We anticipated that potential subgroups for analysis would include
type of intervention (e.g. patient-focused vs practitioner-focused);
timing of intervention delivery, either before or during a consul-
tation; and whether the intervention involved a single episode of
care versus multiple episodes (and whether these were with the
same practitioner). We had planned to carry out subgroup analy-
ses investigating intervention type and delivery, as these would be
of most relevance to practitioners and policy makers looking to im-
plement these types of interventions into practice, to inform them
regarding the most effective approach. To reduce the chance of ob-
serving spurious results by undertaking too many subgroup analy-
ses, we planned to limit subgroups to those of most relevance to
this review. However, there were too few included studies to war-
rant any type of subgroup analyses, as only two studies were in-
cluded per comparison for the review.
Sensitivity analysis
Too few studies, with dissimilar outcome measures, were included
to allow for a thorough sensitivity analysis to assess the robustness
of results, including the impact of notable assumptions, imputed
data, and inclusion of studies at high risk of bias. We planned to re-
move lower-quality studies from the analysis to see how robust the
results would be when based only on higher-quality studies; how-
ever, too few studies were included for this to be feasible. We in-
stead classified studies to be at high, low, or uncertain risk using
the Cochrane 'Risk of bias' tool (Higgins 2011), and we referred to
these classifications during our narrative synthesis of results.
We had also planned to consider formally comparing 'Risk of bias'
assessments using meta-regression; however, a minimum of 10
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studies is recommended for meta-regression for each variable in-
cluded in the model (Thompson 2002). Therefore this also was not
feasible.
'Summary of findings' tables
We prepared Summary of findings for the main comparison and
Summary of findings 2 to present the results for each of the ma-
jor primary outcomes, including the primary adverse outcome, as
outlined in the Types of outcome measures section (with results
presented narratively). We converted results into absolute effects
when possible. Assumed risks cited in the tables were based on
the mean or median risk (dependent on data reported by study au-
thors) and on ranges of risks in the control groups of included stud-
ies. We used the GRADE criteria to rank the quality of the evidence
based on the methods described in Chapter 11 of the Cochrane
Handbook for Systematic Reviews of Interventions (Schünemann
2011).
We used GRADEpro software to prepare the tables (GRADEpro GDT
2015).
Ensuring relevance to decisions in health care
The protocol and the review received feedback from one consumer
referee in addition to a content expert as part of the Cochrane
Consumers and Communication Review Group’s standard editorial
process.
Using links with the patient involvement group from the National
Institute for Health Research (NIHR) Collaboration for Leadership
in Applied Health Research and Care, South West Peninsula (Pen-
CLAHRC), we established a group of eight older members of the
public who have varying degrees of morbidity and varying health
service experiences. We arranged workshops to enable these Pa-
tient and Public Involvement group members to advise on the di-
rection of the review and to ensure end-user relevance of the pre-
sentation of our results.
The lead author is a general practitioner (GP) and therefore has
insight into the relevance of our review to primary health care. In
addition, we sought the opinions of content experts, including pri-
mary healthcare practitioners with a special interest in older pa-
tients and experts on shared decision-making, regarding relevant
evidence and theory, and asked for critical appraisal of our review
methods and results. We discussed methods of delivering our re-
sults that are acceptable, engaging, and sustainable in context, giv-
ing consideration to resource allocation, recruitment issues, and
the format of future evaluation.
R E S U L T S
Description of studies
Results of the search
In total, we identified 8253 citations from electronic database
searches and three additional records from expert contacts in the
research area of interest (see PRISMA diagram in Figure 1). After re-
moving duplicates, two review authors screened 8160 studies by
title and abstract, excluding 8106. A total of 54 remaining full-text
articles appeared to be of relevance to the review. Of these, two
review authors excluded 51 articles (see Characteristics of exclud-
ed studies table for reasons for exclusion). We did not identify any
studies awaiting classification but found one ongoing study that
was relevant to the review.
Included studies
The remaining three articles provided data on three studies that
met our inclusion criteria. The three included studies, involving
1879 participants in total, provided results from three countries:
USA (n = 1), Australia (n = 1), and UK (n = 1). Study details are sum-
marised below, and an in-depth description is provided in the Char-
acteristics of included studies table.
Design
All included studies were reported as RCTs (Hochhalter 2010; Reed
2018; Salisbury 2018). Hochhalter 2010 and Reed 2018 were paral-
lel-group trials, randomised at patient level, each with a study du-
ration of six months. Salisbury 2018 was cluster-randomised at the
practice level with the trial carried out over 15 months.
The three studies differed in their approach to comparator groups:
Hochhalter 2010 used three arms, comparing the intervention to
an attention-control group as well as to usual care; Reed 2018
used two arms, comparing the intervention to an attention-control
group; and Salisbury 2018 used a two-arm design to compare the
intervention with usual care.
As expected by the review authors, studies differed in their defini-
tion of multi-morbidity; however, all three study definitions could
be encompassed by the review's definition of 'more than one long-
term health problem'.
Sample size
Total numbers of randomised participants per study were as fol-
lows: Hochhalter 2010 - n = 79; Reed 2018 - n = 254; and Salisbury
2018 - n = 1546 (33 practices: 16 intervention, 17 usual care).
Setting
The studies were conducted in three different countries. Whilst all
studies were from developed countries and all fulfilled our pre-
specified criteria for a primary care setting, differences in primary
health care delivery between USA, UK, and Australia are evident.
Both Hochhalter 2010 and Reed 2018 report that their intervention
was delivered at patients' usual primary care clinics or at patients'
homes; however, Reed 2018 reported that intervention providers
were not members of patients' usual primary care teams, and the
review authors assumed that this was also the case for Hochhal-
ter 2010, although it was not explicitly reported. In contrast, Salis-
bury 2018 reported that the intervention was delivered by named
responsible members of the primary care team, and that it was de-
livered at the patient's usual general practice.
Participants
Full details of participant characteristics are provided in the Char-
acteristics of included studies table.
Only Hochhalter 2010 specified in its inclusion criteria that patients
should be 65 years of age or older; however, it was possible to deter-
mine (as outlined in the review protocol) that for each study, 75% or
more of the patient population was 65 years of age or older. The av-
erage number of long-term conditions per patient was greater than
three in all studies.
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Each of the studies excluded some important patient groups of rel-
evance to the review. Those with travel difficulties, receiving hos-
pice care, or diagnosed with dementia were excluded by Hochhal-
ter 2010, and information was insufficient to allow conclusions
about other groups, including people with a disability. However,
the mean Charlson Comorbidity Index at baseline for all groups in
Hochhalter 2010 was low, suggesting that those with high risk of
mortality from the combination of their chronic illnesses had not
been included. Reed 2018 excluded those residing in a long-term
care facility, those with terminal illness, those with cognitive im-
pairment, those with hearing loss, and those who did not speak
English. Salisbury 2018 reported that those with a life expectancy
of less than 12 months and those 'unable to complete the question-
naire in English' were excluded.
Both Hochhalter 2010 and Salisbury 2018 participants were pre-
dominantly of white ethnicity; however, Reed 2018 did not provide
information on ethnicity - only on country of birth.
Interventions
Detailed descriptions of the interventions are provided in the Char-
acteristics of included studies table.
Both Hochhalter 2010's 'Making the Most of Your Healthcare' inter-
vention and Reed 2018's 'Chronic Disease Self-Management Sup-
port (CDSMS)' programme were patient-focused interventions us-
ing theory- and evidence-based behaviour change techniques. Sal-
isbury 2018's '3D' intervention was both patient- and practition-
er-focused and addressed organisational change. The intervention
was designed to encapsulate recent international guidance and
strategies for management of patients with multi-morbidity.
Hochhalter 2010 used a workshop and individual 'coaching' phone
calls, both delivered by the research team, with the aims of im-
proving both patients' engagement during healthcare appoint-
ments with their usual clinicians and their health-related qual-
ity of life. Reed 2018 used individual coaching home visits and
phone calls, during which a clinician from the research team used
three standardised assessment and planning tools to "actively as-
sist participants to achieve actions and goals" and to develop a
care plan in collaboration. The intervention was delivered with the
aim of improving patient skills and confidence in managing their
long-term conditions. Salisbury 2018 replaced patients' usual dis-
ease-focused reviews of each health condition with one six-month-
ly comprehensive multi-disciplinary review (consisting of two ap-
pointments) with the patient's healthcare team. The intervention
utilised an integrated electronic template and was delivered with
the aim of improving "continuity, coordination and efficiency of
care" for patients with multi-morbidity.
All three interventions featured content related to patient involve-
ment in decision-making: Hochhalter 2010's workshop included
content on 'making decisions with your doctor' and provided so-
cial support through group discussion about barriers to shared de-
cision-making. Reed 2018's tools focused on facilitated goal-set-
ting and active, collaborative decision-making (between patients
and clinicians) and care plan development and review. Salisbury
2018 encouraged patients to "think about the health problems
that bothered them the most" and trained clinicians to identify pa-
tient priorities and to agree and document a holistic, collaborative
health plan, guided by the patient's priorities.
All three interventions had components that were tailored to the
context of their patient participants' individual healthcare needs.
We provide a summary of the key components of the three inter-
ventions from the included studies below.
• Patient workshop and individual patient coaching: to pro-
vide tools and skills for preparation for consultations, commu-
nication with doctors, and follow-through with collaborative-
ly made plans (using evidence-based behaviour change tech-
niques) (Hochhalter 2010).
• Individual patient coaching: to increase patients’ skills and
confidence in managing their chronic diseases (utilising cogni-
tive-behavioural therapy (CBT) and motivational interviewing
(MI) techniques) (Reed 2018).
• Holistic patient review with practitioner training and organ-
isational change: comprehensive multi-disciplinary patient re-
view to improve continuity, co-ordination, and efficiency of care
(Salisbury 2018).
Outcomes
None of the included studies reported the primary outcome of
the review - 'evidence of patient involvement in decision-making'.
However, all included studies provided data related to three or
more of the secondary review outcomes, namely, health status;
treatment burden; patient enablement and engagement; patient
evaluation of care/the intervention; carer evaluation of care; re-
source use and cost; and quality of care. When studies reported
more than one outcome per category, the highest-ranked outcome
(as outlined in the methods section) is presented for each study
in the Characteristics of included studies table. All secondary out-
comes included in 'Summary of findings' tables were measured by
studies, both at baseline and at the end of the trial.
None of the included studies reported the primary adverse out-
come of less patient involvement as a result of the intervention. In
respect to the other adverse outcomes of interest for this review,
all studies measured accident and emergency department atten-
dance and hospital admissions, although only two studies report-
ed on these outcomes. These outcomes were extracted in the 're-
source use and cost' category, and review authors planned to con-
sider an increase in these outcomes as a result of the intervention
as an adverse event. One study additionally reported on patient
death and patient anxiety.
Theory
The aim of the Hochhalter 2010 intervention was to improve pa-
tient engagement and health-related quality of life through coach-
ing workshops and telephone calls to stimulate behaviour change
in older patients with multi-morbidity. Intervention components
were developed according to the self-determination theory of mo-
tivation (Ryan 2000). This theory recognises three types of mo-
tivation for behaviour change in individuals: perceived ‘compe-
tence’ for a behaviour; perceived ‘autonomy’ (choice) of behav-
iour; and ‘relatedness’ of the behaviour to achieving personal goals.
The review authors interpret that Hochhalter 2010’s ‘Making the
Most of Your Health Care’ intervention therefore provided informa-
tion, offered tools, and taught skills with the aim of providing old-
er patients with multi-morbidity with the ability and self-efficacy
to become involved in decision-making about their health care:
to choose to prepare for healthcare appointments; to choose to
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communicate effectively to gather information and support of rel-
evance to their individual needs during healthcare appointments;
and to choose to follow through on plans of care that were relevant
to their own personal goals.
Reed 2018's ‘Chronic Disease Self-Management Support' (CDSMS)
intervention similarly aims to increase patients' "skills and con-
fidence" but in relation to condition management, as compared
to Hochhalter 2010's aim of improving patient engagement. Reed
2018 argues that motivation and information alone are not suffi-
cient to empower older people with multi-morbidity to become in-
volved in decision-making about their health care (Sevick 2007).
Reed 2018 also considers the need for any behaviour change to be
sustained (or habitual). Study authors report that these patients
can often feel overwhelmed by complex health information and
treatment regimens, and that these problems are amplified by the
cognitive decline associated with multi-morbidity in older age. The
review authors interpret that Reed 2018’s CDSMS intervention was
developed with the aim of providing older patients with the infor-
mation and skills needed to identify problems and goals (in the
hope that these behaviours become sustained/habitual), to reduce
the burden of information-processing associated with self-man-
agement of multiple long-term conditions, and to enable patients
to develop plans to address healthcare priorities with their clini-
cian.
Like Reed 2018, Salisbury 2018 acknowledges the potential burden
of care for patients with multi-morbidity, stating that "if each con-
dition is considered in isolation, patients can be prescribed numer-
ous drugs and lifestyle changes, and are expected to attend fre-
quent health-care appointments”. The patient-centred care mod-
el used in the ‘3D’ intervention is therefore designed to replace
multiple reviews for a patient’s individual chronic conditions with
one multi-dimensional, multi-disciplinary, comprehensive review
of the patient’s multiple conditions. Study authors also report that
intervention components focus on addressing patient priorities
and on motivating and training clinicians to take a holistic ap-
proach when making decisions collaboratively with the patient.
All three studies highlight the importance of priority-setting for old-
er patients with multi-morbidity and the challenges of patient-clin-
ician agreement regarding healthcare priorities.
The theory underpinning the included interventions, as reported by
study authors, can be considered in the context of the wider litera-
ture regarding behaviour change; however, it is beyond the scope
of this review to perform a full analysis of the interventions in this
respect. The Michie 2011 systematic review of frameworks of be-
haviour change interventions found three essential conditions that
must all be present for behaviour change to occur: capability, op-
portunity, and motivation. Hochhalter 2010 addressed capability
and motivation using individual coaching (to 'activate' patients for
involvement in decision-making about their health care) and so-
cially supportive group workshops (which included discussion of
potential barriers for involvement). The review authors also per-
ceive that, by acknowledging the patient's autonomy/choice to be-
come involved in decision-making and by providing the communi-
cation support tools to facilitate patient involvement, Hochhalter
2010 addresses the opportunity for behaviour change. Reed 2018
similarly addressed the skills and motivation of patients by utilising
cognitive-behavioural therapy and motivational interviewing tech-
niques, and by working on patients' self-efficacy for involvement
in decision-making. Reed's aim for sustained behaviour change,
whereby patient identification of personal goals and priorities be-
comes habitual behaviour, would provide further motivation for
patients' continued involvement in decision-making about their
health care. The review authors interpret that Reed's intervention
was also designed to provide opportunity for patient involvement
by reducing the burden of information-processing for patients and
thereby reducing the potential complexity of the decision-mak-
ing process. Salisbury 2018's intervention addressed organisation-
al factors including continuity and multi-disciplinary involvement
to provide the opportunity for behaviour change; the skills and mo-
tivation needed for the desired behaviours were addressed by ask-
ing patients to consider their priorities and by training multi-disci-
plinary practitioners to holistically manage these priorities.
A conceptual model of the theory behind all three interventions, as
described by the included studies, and set in the context of both
the wider behaviour change literature and that of the outcomes of
interest for this review, was developed by JB and is presented in
Figure 2.
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Figure 2.   A conceptual model of the theory underpinning the included interventions, in the context of the wider
behaviour change literature and outcomes of interest for this review.
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All of the data reported in this review were obtained from published
literature and through clarification by correspondence with the au-
thors of two of the studies. The review authors did not have access
to unpublished data. Correspondence with the authors of Hochhal-
ter 2010 was not successful. For Reed 2018, correspondence with
authors by email provided clarification that the questions related
to participant feedback were collected by using participant self-re-
port questionnaires. Answers to the review authors' queries regard-
ing Salisbury 2018 were provided through access to the full trial re-
port.
Excluded studies
We excluded 51 studies (see Characteristics of excluded studies).
Reasons for exclusion were wrong patient population, wrong inter-
vention, wrong setting, and wrong study design.
Risk of bias in included studies
Risk of bias in the included studies is illustrated in the risk of bias
graph (Figure 3), as well as in the risk of bias summary (Figure 4).
The review authors' ratings for each type of bias per study are pre-
sented, along with reasons, in the Characteristics of included stud-
ies table. None of the studies were rated at high risk of bias for any
of the individual criteria assessed.
 
Figure 3.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 4.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
 
Allocation
All three studies were at low risk for selection bias. All studies used
computer-generated randomisation sequences with central allo-
cation, with randomisation taking place after enrolment.
Blinding
The review authors considered subjective and objective measures
separately regarding performance and detection bias.
Reed 2018 reported incomplete blinding (of participants but not
research personnel); however, review authors judged that all out-
comes measured were not likely to have been influenced by this,
and therefore rated Reed 2018 at low risk for performance bias. Re-
view authors assumed that blinding of participants and personnel
was not possible for Hochhalter 2010; however, the study was rat-
ed at unclear risk of bias, as review authors were unsure whether
this could have affected reported outcomes. Salisbury 2018 was al-
so rated as unclear for performance bias, as blinding of participants
and personnel was not undertaken, and again, it is unclear whether
this affected outcomes.
All three included studies were rated at unclear risk for detection
bias: Hochhalter 2010 was rated as unclear overall, as outcomes
of interest were assessed by patient self-report and patients were
not blinded; additionally, the study authors did not report whether
those extracting data from patients' electronic health records were
blinded; Reed 2018 reported insufficient information to make the
judgement; and Salisbury 2018 did not report blinding of outcome
assessment for all outcomes.
Incomplete outcome data
Hochhalter 2010 was judged at low risk for attrition bias: the study
authors used an intention-to-treat (ITT) analysis; there was some
imbalance in participant numbers between groups, but review au-
thors concluded that the imbalance was not enough to classify the
study as high risk. Reed 2018 also conducted an ITT analysis, and
attrition was balanced with the method of imputation clearly re-
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ported; this study was therefore judged to be at low risk for attri-
tion bias. Salisbury 2018 conducted an ITT analysis. Data for some
outcomes ('treatment burden' and 'proportion of patients who dis-
cussed the problems most important to them' at 15 months' fol-
low-up) were lacking; however, the method of imputation was re-
ported for the primary outcome of the study 'quality of life'. Review
authors judged that information was insufficient to allow a clear
judgement on attrition bias.
Selective reporting
Hochhalter 2010 reported that researchers had measured certain
outcomes at baseline and at six months; however, some of these
data were not reported, namely, 'number of outpatient/clinic vis-
its'. Review authors were unable to find the protocol or trial reg-
istration for Hochhalter 2010 and received no response after at-
tempting to contact the study authors; therefore, this study was
judged to be at unclear risk for reporting bias. The protocol was
available for Reed 2018, and all of the study's pre-specified out-
comes had been reported in the pre-specified way. The protocol
was available for Salisbury 2018, and all pre-specified outcomes
were reported either in the paper or in the full report (Salisbury
2018); therefore this study was judged to be at low risk of reporting
bias.
Other potential sources of bias
Salisbury 2018 was additionally assessed for selective recruitment
of cluster participants. This study was judged to be at low risk, as
cluster participants were recruited before group assignment and
the same participants were followed up over time.
Salisbury reported that an intracluster coefficient (ICC) of 0.03 was
assumed for clustering at the practice level based on a previous trial
(Kennedy 2013).
Review authors noted no other obvious sources of bias in any of the
three included studies.
E:ects of interventions
See: Summary of findings for the main comparison Interventions
for involving older patients with multi-morbidity in decision-mak-
ing about their health care compared to usual care for older pa-
tients with multi-morbidity; Summary of findings 2 Interventions
for involving patients in decision-making about their health care
compared to attention-control conditions for older patients with
multi-morbidity
Components of the three interventions were summarised in the De-
scription of studies section as follows.
• Patient workshop and individual patient coaching using evi-
dence-based behaviour change techniques (Hochhalter 2010).
• Individual patient coaching utilising cognitive-behavioural
therapy and motivational interviewing (Reed 2018).
• Holistic patient review with multi-disciplinary practitioner
training and organisational change (Salisbury 2018).
None of the studies reported the primary outcome of the review
- evidence of patient involvement in decision-making about their
health care. Also, no studies reported the primary adverse outcome
of less patient involvement in decision-making as a result of the in-
tervention.
Due to the small number of included studies and substantial clinical
and methodological heterogeneity between studies, it was not pos-
sible to conduct a meta-analysis of findings. Therefore, the findings
from a limited narrative synthesis are presented to explore the re-
lationships between study findings related to the pre-specified sec-
ondary outcome categories. We planned to follow a general frame-
work, as recommended by Popay 2006: review authors first con-
sidered the theory behind the study interventions (see Description
of studies section), then conducted a synthesis of the findings of
studies exploring relationships in the data, and finally assessed the
robustness of the synthesis. (Considerations regarding the robust-
ness of the synthesis are presented in the Discussion sections Qual-
ity of the evidence and Potential biases in the review process.)
Findings are presented below, and those ranked of greatest clinical
relevance and importance to the review's readers are summarised
in Summary of findings for the main comparison and Summary of
findings 2, by outcome category per comparison.
Two comparisons are presented.
• What are the effects of interventions to involve patients in deci-
sion-making about their health care versus usual care for older
patients with multi-morbidity in primary care?
• What are the effects of interventions to involve patients in de-
cision-making about their health care versus attention-control
conditions for older patients with multi-morbidity in primary
care?
No studies reported findings consistent with the third pre-specified
comparison for the review: “What are the effects of an intervention
to involve patients in decision-making about their health care ver-
sus an alternative intervention to involve patients in decision-mak-
ing about their health care for older patients with multi-morbidity?”
As only Hochhalter 2010 compared the intervention to both usual
care and attention-control conditions, findings from only two stud-
ies can be presented per comparison.
What are the e:ects of interventions to involve patients in
decision-making about their health care (patient workshop
and individual coaching, holistic patient review plus multi-
disciplinary practitioner training, and organisational change)
versus usual care for older patients with multi-morbidity?
Hochhalter 2010 and Salisbury 2018 compared intervention to usu-
al care. Whilst both studies reported outcomes of relevance to com-
mon outcome categories for the review, these studies did not mea-
sure any of the same outcomes. We report their findings below by
outcome category.
Patient and carer outcomes - health status
Hochhalter 2010 measured patient-reported ‘self-rated health’ us-
ing the 5-point Centers for Disease Control and Prevention (CDC)
'Healthy Days Measure' (CDC 2000). From these study findings, it is
uncertain whether the ‘Making the Most of Your Health Care’ inter-
vention affects participant reports of high self-rated health when
compared to usual care at six months (risk ratio (RR) 1.40, 95% con-
fidence interval (CI) 0.36 to 5.49; P = 0.63; very low-certainty evi-
dence (Analysis 1.1)). Certainty of evidence was downgraded for im-
precision (small sample size), and because results were drawn from
a single study in a developing evidence base.
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Salisbury 2018 measured health-related quality of life using pa-
tient-reported EuroQoL Group Quality of Life Questionnaire based
on a five-level scale (EQ-5D-5L) scores (Herdman 2011). This study's
primary analysis with missing data imputed suggests that there
is probably no difference between study groups in health-related
quality of life at 15 months (adjusted difference in means 0.00, 95%
CI –0.02 to 0.02; P = 1.00; moderate-certainty evidence (Analysis
1.2)). Certainty of evidence was downgraded because all results
were drawn from a single study in a developing evidence base. Also,
performance bias and detection bias were unclear, which had the
potential to affect the outcome; however, this was not considered
a 'serious' risk.
Both measures of health status were considered clinically impor-
tant by review authors; therefore, both are reported in Summary of
findings for the main comparison.
Patient and carer outcomes - treatment burden
Salisbury 2018 measured treatment burden by asking patients
to complete the Multi-morbidity Treatment Burden Questionnaire
(MTBQ) (Duncan 2018). There is probably no difference in MTBQ
score (mean (SD)) between intervention (12.9 (15.0)) and control
(15.0 (17.1)) at 15 months, based on an adjusted multi-level linear
regression model (beta-coefficient –0.46, 95% CI –1.78 to 0.86; P =
0.49; moderate-certainty evidence (Analysis 1.3)). Certainty of evi-
dence was downgraded because all results were drawn from a sin-
gle study in a developing evidence base. Lack of clarity regarding
performance bias and detection bias was not considered a 'serious'
risk.
Patient and carer outcomes - patient enablement and
engagement
Hochhalter 2010 used the Patient Activation Measure to assess pa-
tient enablement as a result of the study intervention (Hibbard
2005). It is uncertain whether there is a difference between inter-
vention and usual care groups in Patient Activation Measure scores
at six months (mean difference (MD) 0.60, 95% CI -9.23 to 10.43; P
= 0.9; very low-certainty evidence (Analysis 1.4)). Certainty of evi-
dence was downgraded for imprecision (small sample size), and be-
cause results were drawn from a single study in a developing evi-
dence base. Lack of clarity regarding performance bias, detection
bias, and reporting bias had the potential to affect the outcome;
however, this was not considered a 'serious' risk.
Salisbury 2018 used the Morisky Medication Adherence Scale to
measure medication adherence (Morisky 2008), which the review
authors considered to be an aspect of patient engagement. Salis-
bury's findings suggest that there is probably no difference in score
(mean (SD)) between intervention (6.7 (1.2)) and control (6.6 (1.3))
at 15 months based on an adjusted multi-level linear regression
model (beta-coefficient 0.06, 95% CI –0.05 to 0.17; P = 0.28; mod-
erate-certainty evidence (Analysis 1.5)). Certainty of evidence was
downgraded because all results were drawn from a single study in
a developing evidence base. Lack of clarity regarding performance
bias and detection bias was not considered a 'serious' risk.
Patient and carer outcomes - patient evaluation of care/the
intervention
Salisbury 2018 reported on aspects of patient evaluation of the
care received. Study authors used a single question adapted from
the National Health Service (NHS) General Practice Patient Survey
and dichotomised the 5-point scale by patient reports of discussing
their most important problems ('almost always' vs 'not at all' +
'rarely' + 'some of the time') (Ipsos MORI 2015). Study findings sug-
gest that there were probably greater numbers of intervention par-
ticipants (42%) than control participants (26%) reporting that they
'almost always discuss the problems most important to them in
managing their own health' at 15 months. Salisbury 2018 reported
findings from multi-level ordinal logistic regression (adjusted odds
ratio 1.85, 95% CI 1.44 to 2.38; P < 0·00001; moderate-certainty ev-
idence (Analysis 1.6)). Certainty of evidence was downgraded be-
cause all results were drawn from a single study in a developing ev-
idence base. Lack of clarity regarding performance bias and detec-
tion bias was not considered a 'serious' risk.
Patient and carer outcomes - patient perceptions or ratings of
carer support
None of the included studies measured patient perceptions or rat-
ings of carer support.
Patient and carer outcomes - carer evaluation of care
Salisbury 2018 was the only study that reported any carer outcomes
(data taken from the full trial report). Study authors used a six-item
carer experience questionnaire, with responses transformed to a
profile measure value between 0 and 100 (Al-Janabi 2011). It is un-
certain whether there is evidence of improved carer experience in
the intervention arm at 15 months when compared with usual care
(adjusted difference in means 6.51, 95% CI 0.25 to 12.77; P = 0.042;
very low-certainty evidence; (Analysis 1.7)). Certainty of evidence
was downgraded for imprecision (small sample size), and because
all results were drawn from a single study in a developing evidence
base. Lack of clarity regarding performance bias and detection bias
was not considered a 'serious' risk.
Practitioner outcomes
The included studies did not measure the review’s pre-specified
practitioner outcomes: practitioner knowledge and skills; practi-
tioner attitudes (towards the intervention and compliance with it);
and practitioner satisfaction with the intervention.
Health service outcomes - resource use and cost
Resource use was measured in terms of numbers of consultations.
Findings for the numbers of outpatient/clinic visits were reported
to have been measured but were not published by Hochhalter 2010,
and review authors received no response from study authors to
their request for these data.
Salisbury 2018 reviewed routine medical records. Findings suggest
that patients in the intervention group probably attended more
nurse consultations at 15 months when compared with the usual
care group (incident rate ratio from adjusted multi-level Poisson
model 1.37, 95% CI 1.17 to 1.61; P = 0.0001; moderate-certainty ev-
idence (Analysis 1.8)). Certainty of evidence was downgraded be-
cause all results were drawn from a single study in a developing ev-
idence base. Lack of clarity regarding performance bias and detec-
tion bias was not considered a 'serious' risk.
Health service outcomes - quality of care
Salisbury 2018 looked at indicators of high-risk prescribing as a
measure of quality of care by reviewing patients’ electronic health
records and using an approach developed for a previous trial (Dreis-
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chulte 2016). Study findings suggest that there is probably no dif-
ference between intervention and usual care in the number of in-
dicators of high-risk prescribing at 15 months (incident rate ratio
from adjusted multi-level Poisson model 1.04, 95% CI 0.87 to 1.25;
P = 0.65; moderate-certainty evidence (Analysis 1.9)). Certainty of
evidence was downgraded because all results were drawn from a
single study in a developing evidence base. Lack of clarity regard-
ing performance bias and detection bias was not considered a 'se-
rious' risk.
Adverse outcomes
The review’s primary adverse outcome of less patient involvement
in decision-making than before the intervention was not measured
by the included studies.
Salisbury 2018 recorded full details of participant death and re-
ported no differences between intervention and usual care groups
and no association between death and the intervention. These in-
vestigators also reported no difference in participant anxiety be-
tween intervention and usual care groups. Increases in accident
and emergency attendances or hospital admissions were also pre-
specified adverse outcomes for the review. Emergency department
visits and hospital admissions were measured by both Hochhalter
2010 and Salisbury 2018; however, these findings were not report-
ed by Hochhalter 2010, and review authors' attempts to correspond
with these study authors were unsuccessful. Salisbury 2018 found
no difference between intervention and usual care groups with re-
spect to these outcomes.
What are the e:ects of interventions to involve patients in
decision-making about their health care (patient workshop
and individual coaching, individual patient coaching) versus
attention-control conditions for older patients with multi-
morbidity?
Hochhalter 2010 and Reed 2018 compared intervention to atten-
tion-control conditions.
Patient and carer outcomes - health status
Hochhalter 2010 dichotomised participants’ 5-point scores on the
CDC 2000 scale for self-reported health and reported low scores
(1 to 3) and high scores (4 to 5). It is uncertain whether more at-
tention-control participants reported high self-rated health when
compared to intervention participants at six months (RR 0.38, 95%
CI 0.15 to 1.00; P = 0.05; very low-certainty evidence (Analysis 2.1)).
Certainty of evidence was downgraded for imprecision (small sam-
ple size), and because results were drawn from a single study in a
developing evidence base.
Conversely, Reed 2018 used a similar 5-point scale initially devel-
oped for the US National Health and Nutrition Examination Sur-
vey. Review authors converted the 5-point Likert scores reported
by Reed 2018 to low scores (1 to 3) and high scores (4 to 5) to draw
comparisons with the findings reported by Hochhalter 2010. From
the Reed 2018 data, it is uncertain whether more intervention par-
ticipants than attention-control participants have high self-rated
health scores at six months (RR 2.17, 95% CI 0.85 to 5.52; P = 0.11;
very low-certainty evidence (Analysis 2.1)). Certainty of evidence
was downgraded for imprecision (small sample size), and because
results were drawn from a single study in a developing evidence
base.
Due to high heterogeneity between studies (I2 = 85% on test-
ing a random-effects model for meta-analysis), the results from
Hochhalter 2010 and Reed 2018 were not pooled. Findings for both
studies are illustrated on a non-pooled forest plot (Analysis 2.1),
where the opposite directions of effect can be clearly visualised.
Patient and carer outcomes - treatment burden
Neither study reported on this outcome.
Patient and carer outcomes - patient enablement and
engagement
Hochhalter 2010 reported Patient Activation Measure scores at
six months for attention-control and intervention groups (Hibbard
2005). It is not certain whether there is a difference in Patient Ac-
tivation Measure score at six months between intervention and at-
tention-control groups (MD 1.20, 95% CI -8.21 to 10.61; P = 0.8; very
low-certainty evidence (Analysis 2.2)). Certainty of evidence was
downgraded for imprecision (small sample size), and because re-
sults were drawn from a single study in a developing evidence base.
Additionally, 95% confidence intervals showed no effect.
Reed 2018 measured patient self-efficacy using the 'self-efficacy for
managing chronic disease scale' (Stanford 2018). It is not certain
whether there is a difference in mean scores between intervention
and attention-control groups at six months (MD 0.29, 95% CI -0.21
to 0.79; P = 0.26; very low-certainty evidence (Analysis 2.3)). Certain-
ty of evidence was downgraded for imprecision (small sample size),
and because results were drawn from a single study in a developing
evidence base. Additionally, 95% confidence intervals showed no
effect.
Both of these measures of patient enablement and engagement
were considered clinically important by review authors; therefore,
both are reported in Summary of findings 2.
Patient and carer outcomes - patient evaluation of care/the
intervention
Reed 2018 measured patient evaluation of care received using the
patient self-report to determine whether patients regarded the pro-
gramme as having changed the management of their health care
(correspondence with study authors confirmed that self-report oc-
curred via patient questionnaire, not via interview, as incorrect-
ly stated in the paper). Researchers used a three-point scale, di-
chotomised for analysis into 'a great deal' versus 'somewhat' + 'not
at all'. The intervention may increase the number of participants re-
garding the programme as ‘having changed management’ of their
health conditions (RR 1.82, 95% CI 1.35 to 2.44; P < 0.0001; low-
certainty evidence (Analysis 2.4)). Certainty of evidence was down-
graded for imprecision (small sample size), and because results
were drawn from a single study in a developing evidence base.
Practitioner outcomes
The included studies did not measure the review’s pre-specified
practitioner outcomes: practitioner knowledge and skills; practi-
tioner attitudes (towards the intervention and compliance with it);
and practitioner satisfaction with the intervention.
Health service outcomes - resource use and cost
Findings for the numbers of outpatient/clinic visits were not re-
ported by Hochhalter 2010, and the review authors received no
correspondence from study authors in response to a request for
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these data. The review authors believe that these data would have
contributed to any certain evidence of effect, however, based on
GRADE assessments for all other outcomes reported by Hochhalter
2010 alone.
Reed 2018 reported absolute numbers of general practice visits re-
ported by participants. However, it is not certain whether interven-
tion participants reported more general practice visits during the
study when compared to attention-control participants at the end
of the six-month trial (MD 0.51, 95% CI -0.34 to 1.36; P = 0.24; very
low-certainty evidence (Analysis 2.5)). Certainty of evidence was
downgraded for imprecision (small sample size), and because re-
sults were drawn from a single study in a developing evidence base.
Additionally, this outcome was measured by patient self-report as
opposed to using an objective measure.
Health service outcomes - quality of care
Neither study reported on this outcome.
Adverse outcomes
The review’s primary adverse outcome of less patient involvement
in decision-making than before the intervention was not measured
by the included studies.
Emergency department visits and hospital admissions were mea-
sured by both Hochhalter 2010 and Reed 2018; however, these find-
ings were not reported by Hochhalter 2010, and attempts to cor-
respond with the study authors were unsuccessful. Reed 2018 re-
ported no difference between intervention and attention-control
groups, and therefore no adverse effects of the intervention on ei-
ther of these outcomes.
D I S C U S S I O N
Summary of main results
The results of greatest clinical importance and relevance to the re-
view are summarised in the summary of findings tables based on
the pre-specified priority outcome categories (Summary of find-
ings for the main comparison; Summary of findings 2). No studies
that measured the primary outcome 'patient involvement in deci-
sion-making' were found, and no studies looked at the primary ad-
verse outcome 'evidence of less patient involvement as a result of
the intervention'.
From the original 8256 studies identified, three studies were includ-
ed in the review, with only two studies of relevance per comparison.
Some aspects of risk of bias were unclear across studies, particu-
larly in relation to performance bias, detection bias, and reporting
bias; however, no studies were rated at high risk for any of the as-
pects of bias that were assessed.
All but one of the secondary outcomes (namely, health status,
treatment burden, patient enablement and engagement, patient
evaluation of care/the intervention, carer evaluation of care, re-
source use and cost, and quality of care) were reported by a single
study. Two out of three included studies had small participant num-
bers; this is the main reason for uncertainty in the review findings.
We are uncertain as to whether interventions for involving patients
in decision-making about their health care can improve reports of
self-rated health or patient activation for older patients with mul-
ti-morbidity when compared with usual care. We are uncertain as
to whether interventions for involving patients in decision-making
about their health care improve reports of self-rated health, patient
activation, or self-efficacy, or alter the number of general practice
visits for older patients with multi-morbidity when compared with
attention-control conditions.
We can report, with moderate certainty, that compared with usual
care, involving patients in decision-making about their health care
probably makes little or no difference in patient-reported health-
related quality of life, or in enablement as assessed via medication
adherence, for older patients with multi-morbidity.
However, involving older patients with multi-morbidity in deci-
sion-making about their health care probably increases patients'
perceptions that the care received is related to their priorities when
compared to usual care (moderate-certainty evidence); is probably
associated with an increase in the number of nurse consultations
when compared to usual care (moderate-certainty evidence); and
may increase patient perceptions of changes in the management of
their health when compared to attention-control conditions (low-
certainty evidence).
Whilst the primary adverse outcome for this review was not re-
ported, two out of the three included studies reported on hospital
admissions and accident and emergency attendances. Studies re-
ported no increase in either of these outcomes as a result of the in-
tervention, when compared with usual care or with attention-con-
trol. Therefore, these 'resource use and cost' outcomes were not
reported to have been adversely affected by the intervention; how-
ever, they have been included in this category of the summary of
findings tables for transparency of reporting. The largest included
study additionally reported that the intervention had no effect on
participant death nor anxiety when compared with usual care.
Overall completeness and applicability of evidence
Identified studies were not sufficient to address all of the objectives
of the review. Whilst the pre-specified primary outcome of the re-
view 'evidence of patient involvement in decision-making' was not
the endpoint of the included trials (and therefore was not explicitly
measured by any of the included studies), it is apparent in the the-
oretical underpinning of each of the interventions evaluated by the
included trials.
The population investigated in each of the included studies was
the participant population pre-specified for the review, and inter-
ventions were consistent with those pre-specified. However, only
one study had intervention components that focused on practition-
ers and organisational change, in addition to the focus on patients,
which was common to all included studies.
The review authors systematically mapped the outcomes report-
ed in the included studies against the secondary outcome cate-
gories identified as of importance in the review protocol. The in-
cluded studies' outcomes covered nearly all of our pre-specified
categories, including patient and carer outcomes of 'health sta-
tus', 'treatment burden', 'patient enablement and engagement',
'patient evaluation of care/the intervention', 'carer evaluation of
care', and the health service outcome of 'resource use and cost'.
These studies did not cover any of our pre-specified practitioner
outcomes, although one of the studies evaluated an intervention
that was partially practitioner-focused. Despite the breadth of cov-
erage of pre-specified outcome categories, due to the small num-
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ber of included studies, there was little overlap in the actual out-
come measures used, and this limited the comparability of the spe-
cific outcomes reported.
The only findings with any certainty of evidence (of effect or
of no effect) were related to the review’s outcomes of interest
when intervention was compared with usual care. These findings
were from Salisbury 2018, which evaluated a complex intervention
that involved holistic patient review, multi-disciplinary practitioner
training, and organisational change (with moderate-certainty evi-
dence).
Salisbury 2018 found no evidence of a difference between groups in
patient-reported health-related quality of life; however, study au-
thors found that larger numbers of 3D intervention participants re-
ported that the care received related to their own priorities. The
odds ratio for the latter, of 1.85, could be clinically meaningful, and
the approach used in the 3D intervention resulting in these two out-
comes could be generalisable to similar populations from countries
other than UK.
Salisbury 2018’s finding that, during the trial period, there were
more nurse consultations in the intervention group than in the usu-
al care group had an odds ratio of 1.37 and could be interpreted as
clinically relevant. This finding may be less applicable in primary
care settings where usual practice is not based on nurse-led review
of long-term conditions, as it is in UK. However, this finding is in-
teresting, given that the aim of the intervention was to reduce the
number of individual disease-focused nurse reviews and to replace
them with one multi-disciplinary six-monthly review. Study authors
did not report any conclusions regarding this; however, only 49%
of intervention participants had two 3D reviews in 15 months as in-
tended. All intervention and usual care participants had a mean of
three long-term conditions from a list of seven, suggesting that usu-
al care participants should have attended at least three annual re-
views - one review per condition. Therefore, the intervention may
have increased the number of nurse consultations for other rea-
sons, not only for routine review of long-term conditions, and this
outcome measure is likely to be vulnerable to confounding. How-
ever, without further studies against which to draw comparisons, it
is beyond the scope of this review to comment on reasons for these
findings without speculation.
When intervention and attention control were compared, the on-
ly findings with positive and significant effects were reported by
Reed 2018, which assessed the effects of individual patient coach-
ing (with low-certainty evidence). These researchers found that a
higher proportion of patient participants receiving the Chronic Dis-
ease Self-Management Support (CDSMS) programme felt that the
care received had changed management of their health when com-
pared to reports from the attention-control group. The risk ratio of
1.82 suggests that this finding could be clinically meaningful. When
older patients are provided with the skills to identify problems and
goals, to reduce the burden of information-processing associated
with self-management of multiple long-term conditions, and to en-
able them to address healthcare priorities with their clinician, they
perceive greater changes in the management of their health care.
This concept could be transferable to other countries, to both pri-
mary and secondary care settings, and to any scenario in which
changes to the patient's health care are required.
The only outcome that was reported by more than one study was
patient ‘self-reported health’, measured similarly on 5-point scales
by both Hochhalter 2010 and Reed 2018 when comparing interven-
tions with attention controls. This was also the only outcome for
which Hochhalter 2010 findings came close to showing evidence of
effect (P = 0.05), but with very low-certainty evidence. Reed 2018
and Hochhalter 2010 reported different directions of effect, how-
ever, with Hochhalter 2010 reporting higher self-rated health in
the attention-control group, and Reed 2018 favouring the interven-
tion. Hochhalter was a much smaller study than Reed and there-
fore should carry less weight in the interpretation of these find-
ings; however, when findings from Reed 2018 were dichotomised
for comparison with findings from Hochhalter 2010, there was no
longer evidence of effect in the Reed 2018 findings and evidence
was of low certainty. There were some similarities in the theo-
ry underpinning the interventions delivered by both Hochhalter
2010 and Reed 2018, with Reed 2018 additionally aiming to reduce
the burden of information-processing for intervention group par-
ticipants. Although carried out in different countries, intervention
delivery was comparable between the two studies, as both used
members of the research team to deliver a combination of face-to-
face components and at-a-distance phone calls; however, Hochhal-
ter 2010 provided a group workshop and Reed 2018 additionally
used one-on-one home visits (see Characteristics of included stud-
ies). Reed 2018 had greater intensity of intervention delivery, us-
ing three home visits and four follow-up phone calls, compared to
Hochhalter 2010’s one workshop and two phone calls approach. It
is difficult to draw comparisons between the two study populations
due to lack of, or inconsistency in, reported data. It is tentatively
proposed that greater intensity of intervention delivery, when seek-
ing to involve patients in decision-making about their care, might
be expected to yield greater improvements in patient self-reported
health when compared to less intensive delivery. However, this re-
mains to be tested in robust trials.
In consideration of the comparison groups used by included stud-
ies, details provided by study authors were insufficient to enable
the review authors to compare the 'usual care' groups used by
Hochhalter 2010 and Salisbury 2018. However, the review authors
are aware that with these types of complex interventions, the size
of the difference between intervention and usual care arm compo-
nents can often vary greatly between trials. This can lead to het-
erogeneity in effects. Both of the attention-control groups used by
Hochhalter 2010 and Reed 2018 were patient-centred and were giv-
en the aim of controlling for the potential positive benefits of re-
ceiving attention from a health professional. The provision of 'pos-
itive attention' to control participants may explain why there were
small, if any, differences between intervention and attention-con-
trol groups, however.
Quality of the evidence
Despite the overall good quality of included studies, the body of ev-
idence identified does not allow for a robust conclusion regarding
review objectives. The synthesis was limited due to only three in-
cluded studies with 1879 participants in total.
Hochhalter 2010 was limited by a small sample size (n = 79); the
study was therefore likely to lack precision in estimates of effects on
secondary outcomes of interest in this review (see Summary of find-
ings for the main comparison; Summary of findings 2). As Hochhal-
ter 2010 was the only study common to both of our comparisons, it
is difficult to draw any meaningful conclusions regarding relation-
ships between data provided by the included studies.
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All studies excluded from the trial some potentially important sub-
groups of the population of interest. Patients excluded by at least
one study were those with travel difficulties, those with a terminal
illness or receiving hospice care, those with cognitive impairment
or diagnosed with dementia, those residing in a long-term care fa-
cility, those with hearing loss, and those who do not speak Eng-
lish. Such restrictions may limit applicability of the findings of these
studies, even when considered for this highly focused population
group.
Only one outcome was commonly measured across studies: ‘self-
rated health’, as measured by Hochhalter 2010 and Reed 2018.
However, there was inconsistency in the direction of effect and no
strong evidence of effect reported by either study with respect to
this outcome, and the certainty of evidence was very low.
The included studies assessed outcomes typically at 6 months and
at 15 months, and there was no apparent pattern in these find-
ings in relation to outcome time points. Long-term follow-up of out-
comes is important in trials of interventions; however, it may be un-
realistic to expect such sustained effects on the outcomes sought
by this review for interventions of this type.
Two review authors independently rated the quality of included
evidence for the outcomes of interest using the GRADE method
and compared assessments (Schünemann 2011). There were no
discrepancies in GRADE assessments between review authors. The
GRADE assessments for certainty of evidence ranged from very low
to moderate across all outcomes. Only some findings from Salis-
bury 2018, comparing intervention to usual care, were rated with
moderate certainty (downgraded from high certainty on the ba-
sis that all results were from the same study in a developing ev-
idence base). Therefore, conclusions were drawn regarding prob-
able evidence of effect for those outcomes. The certainty of evi-
dence for each outcome when intervention was compared to atten-
tion control was assessed as ‘low’ or ‘very low’ (downgraded large-
ly on the basis of small sample size, with all results coming from
the same study, and for the one common outcome, because effects
were in opposite directions); therefore, all findings for this compari-
son were interpreted with caution when the narrative synthesis was
prepared, and when conclusions for the review were decided. As
a result of the low or very low certainty of evidence for many out-
come measures, future research is likely to change the findings of
this review.
Potential biases in the review process
The inclusion criteria stated that only randomised controlled trials
(RCTs), cluster-RCTs, and quasi-RCTs were to be included in the re-
view. It may be that more relevant studies would have been found
by widening the search to include greater methodological hetero-
geneity. This might allow for a thorough narrative synthesis of find-
ings for translation into clinical practice.
Correspondence with study authors was successful for two of
the three included studies, and all queries regarding relevant da-
ta were answered satisfactorily by responses, with no assump-
tions required for interpretation of findings for Reed 2018 or Sal-
isbury 2018. The review authors were unable to obtain data from
study authors for Hochhalter 2010 related to the reportedly mea-
sured outcome of ‘numbers of outpatient/clinic visits’; however,
all data were available for the priority outcomes as presented in
the summary of findings tables. It was not possible to clarify the
background and qualifications of health "coaches" delivering the
Hochhalter 2010 intervention (assumed to have been part of the re-
search team), or to obtain further detail regarding the “recruitment
area” for the Hochhalter 2010 study. This would have assisted in-
terpretation of the context and transferability of the intervention in
practice. In addition, Hochhalter 2010 was assumed to be a parallel
trial, although this was not made explicit by the study authors.
Bias was minimised in searching, study selection, and data col-
lection by two review authors carrying out each aspect of the
work independently. Any discrepancies were resolved by discus-
sion. Two review authors ranked and selected outcomes of clini-
cal importance/relevance using the methods outlined, to reduce
the potential for bias from subjective judgements. With regard to
adverse events, in some cases, the review's pre-specified adverse
events related to worsening of the outcomes that were extracted
under the 'resource use and cost' outcome category (e.g. hospital
admissions, accident and emergency attendance). Interventions
were not reported to have adversely affected (increased) these out-
comes in the included studies; however, for transparency, these
potential adverse outcomes have been mentioned in Summary of
findings for the main comparison and Summary of findings 2.
It was not possible to conduct pooled analysis of outcomes due to
heterogeneity across studies, and because included trials used dis-
similar secondary outcome measures. Pooling of the one common
measure 'high self-rated health' and meta-analysis of these results
were ruled out on the basis of heterogeneity (I2 = 85%) and effects in
opposite directions. However, the review authors used guidance on
the narrative synthesis to structure their exploration and presenta-
tion of the limited findings to allow transparency in interpretation
of results (Popay 2006).
Agreements and disagreements with other studies or
reviews
As described in the methods section, the review authors were very
specific about the way in which the term 'multi-morbidity' was op-
erationalised with respect to our screening and selection criteria to
maintain a focus on the right population for the review, while look-
ing broadly at the effects of relevant interventions. For example,
studies were excluded that did not measure specific long-term con-
ditions but instead reported health ‘domains’ or ‘problems’; stud-
ies were excluded if less than 100% of participants (rather than
a majority) had multi-morbidity; and the review authors did not
consider polypharmacy to always equate to multi-morbidity; there-
fore, polypharmacy was not used as an eligibility criterion. With re-
spect to the included interventions, those with decision goals that
had been pre-specified by a practitioner, whereby the aim was to
persuade the patient to meet those goals, and those related to hy-
pothetical decisions and advanced directives, were excluded. Addi-
tionally, all interventions focusing on organisational change were
included only if they were ‘aiming to facilitate the involvement of
older patients with multi-morbidity in decision-making about their
health care’. We considered the role of our eligibility criteria in the
context of any agreements and disagreements with other reviews
presented below.
The Wetzels 2007 Cochrane systematic review of interventions for
improving older patients' involvement in primary care episodes
found very little available data. Although our review was more fo-
cused than that of Wetzels, limiting the patient population to those
with multi-morbidity, we too found only three included studies. The
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review authors nevertheless expected to find more relevant studies
due to the perception that this is a topical and expanding field of
research.
The Smith 2016 Cochrane systematic review did not design its
search strategy to find studies of interventions to facilitate involve-
ment of older patients with multi-morbidity in decision-making
about their care (see Table 1), and review authors excluded the out-
comes of attitude and knowledge when reporting studies that we
felt to be very important for this review. Therefore, the studies in-
cluded by Smith 2016 did not fulfil the criteria for inclusion in this
review. Additionally, Smith 2016 did not include Hochhalter 2010;
both Salisbury 2018 and Reed 2018 were published after comple-
tion of the Smith review, and therefore could not have been in-
cluded. However, Smith 2016 identified 18 trials of interventions to
improve outcomes for people with multi-morbidity and common
comorbidities in primary care and community settings. These re-
view authors found considerable heterogeneity between studies
and similarly concluded that there were remaining uncertainties
about the effectiveness of interventions for people with multi-mor-
bidity in general.
Bunn 2018 conducted a realist synthesis of a broader evidence
base, supporting shared decision-making for older people with
multiple health and social care needs (as opposed to multiple long-
term health problems). Of 88 review items selected for screening,
46 primary research studies were included, of which five were RCTs.
However, these RCTs did not fulfil the inclusion criteria for this re-
view. Bunn 2018’s patient population of interest was nevertheless
similar to ours. Bunn 2018 concluded that programmes and inter-
ventions likely to be successful in promoting shared decision-mak-
ing are ‘those that allow older people to feel that they are respected
and understood, and that engender confidence to engage in shared
decision-making’. This concept fits with the theory underpinning
our included studies, and previous research using expert advisory
groups has identified 'patient priority-directed care' as a feasible
and sustainable approach for older patients with multi-morbidities
(Tinetti 2016).
Coulter 2015 conducted a systematic review to assess the effects
of personalised care planning for adults with long-term health con-
ditions. This review did not focus on older people with multi-mor-
bidity; however, these review authors were interested in interven-
tions in which active involvement of patients in treatment and
management decisions was a key component, and all of their in-
cluded studies had interventions designed to support behaviour
change among patients with respect to this - a common theme
in our included studies. Coulter 2015 concluded that personalised
care planning leads to improvement in certain indicators of phys-
ical and psychological health status and in people's capability to
self-manage their condition when compared to usual care.
There are additional barriers and facilitators to patient involve-
ment in decision-making about their health care (Butterworth
2014), some of which relate to system factors (including access
to healthcare appointments, continuity of care, and consultation
duration) that were not directly addressed by our review, despite
Salisbury 2018's organisational change approach. Legare 2008 ex-
plored barriers to shared decision-making in that systematic re-
view, focusing on practitioner perspectives, and found that the
most frequently reported barrier was time constraints.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
The current evidence base on effects of interventions for involv-
ing older patients with multi-morbidities in decision-making about
their health care is simply too limited to interpret with any certain-
ty.
Current interventions to involve older patients with multi-morbidi-
ties in decision-making about their health care appear, probably, to
make little or no difference in health-related quality of life as per-
ceived by patients. It may be, however, that current interventions
lack potency, and that a much larger effect on patient involvement
in decision-making is required to affect clinical outcomes, although
Salisbury 2018 highlights, from a systematic review of interventions
for multi-morbidities (see the Appendix), that very little has been
shown to improve quality of life in patients with multi-morbidities.
Interventions to involve older patients with multi-morbidities in
decision-making about their health care appear, probably, to in-
crease patient perceptions that the care they receive relates to their
priorities. This type of intervention may also increase patient per-
ceptions of changes made to management of their health. Impli-
cations for practice regarding these findings depend on the per-
ceived weighting and importance of these outcomes for older pa-
tients with multi-morbidities and their practitioners in the context
of primary care. Currently, evidence is insufficient to identify defin-
itive implications.
Implications for research
Whilst patient involvement in decision-making is seen as a key
mechanism for improving care in almost all recent guidelines and
frameworks on the topic of multi-morbidity (American Geriatric So-
ciety Expert Panel 2012; Muth 2014; NICE 2016; Palmer 2018), this is
rarely tested as an intervention and was not measured for older pa-
tients with multi-morbidity in primary care settings by our included
studies. The review authors conclude that very few RCTs have eval-
uated the effectiveness of interventions to facilitate involvement
of older patients with multi-morbidity in decision-making about
their primary health care. Therefore, there is currently a large gap
between the substantial amount of guidance recommending im-
proved patient involvement in decision-making and an evidence
base to support implementation of this guidance, particularly for
older patients with multi-morbidity in primary care settings.
More research is required to provide clinicians, researchers, and
policy makers with the best evidence to provide good-quality care
for older patients with multiple health problems. The consensus
view, from a 2018 symposium involving experts in the field of mul-
ti-morbidity research, is that there is 'a need for a truly patient-cen-
tred care that takes into account the individual patient from a com-
prehensive and multi-dimensional perspective and acknowledges
the complexity and dynamics of older adults' health' (Calderón-
Larrañaga 2019).
Researchers should seek ways to include important and vulnera-
ble populations that are frequently excluded from trials, including
those receiving end-of-life care, those with cognitive decline, those
residing in long-term care facilities, and those with potential lan-
guage barriers.
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Studies, in assessing this patient group, should also consider the
increasingly diverse nature of the 'older' age category caused by
increasing life expectancy. Additionally, the implications of this re-
view are relevant to younger populations with increasing preva-
lence of multi-morbidity, including socially deprived populations,
for example.
Consistency in intervention design (including transparency in the
theory underpinning the design), analysis, and evaluation would
enable greater likelihood of comparable findings across studies in
future systematic reviews. As the underlying themes in the theo-
ry underpinning our included studies can be related to behaviour
change (Michie 2011), future intervention development and evalu-
ation might usefully take account of 'capability/skills', 'motivation',
and 'opportunity' for both patients and practitioners in the context
of patient involvement in decision-making about their health care.
Other potential sources of theory might also come from the wider
decision theory literature (Hansson 2005), for example. Future in-
terventions and new models of care should be described with the
aid of transparent tools and frameworks (e.g. the ‘TIDier’ checklist
(Hoffmann 2014), ‘the Foundations Framework for Developing and
Reporting New Models of Care for Multimorbidity’ (Stokes 2017)) to
allow comparisons to be drawn between studies and to gauge gen-
eralisability and transferability of findings. A new model for clinical
decision-making in patients with multi-morbidity is currently under
development (Jack 2018), and a full, definitive RCT to determine
the effectiveness of goal-setting for patients with multi-morbidity
to improve outcomes in primary care is anticipated (Steel 2016).
Several validated measures of shared decision-making are cur-
rently available (Gärtner 2018), and it is possible to measure out-
comes from patient, practitioner, and external observer perspec-
tives. However, measures of shared decision-making are yet to be
utilised in trials involving older patients with multi-morbidity con-
sulting in primary care. Application of such measures would en-
courage reporting of coherent outcomes with standardised inter-
vals across trials to benefit future systematic reviews of these find-
ings.
Measuring patient preferences for and experiences of care will be
crucial to the development of interventions that provide high-qual-
ity care directed towards older patients with multi-morbidity (But-
terworth 2014; Valderas 2019).
Potential secondary outcome measures should also be validated
and could include measures specifically designed for use in old-
er populations such as those measuring potentially inappropriate
prescribing (Campanelli 2012; O’Mahony 2015). The Primary Care
Outcomes Questionnaire (PCOQ) was recently developed to specif-
ically measure primary care-oriented outcomes (Murphy 2018). Fu-
ture studies could usefully report practitioner outcomes in terms
of knowledge and skills gained, attitudes towards the intervention,
and compliance with the intervention (Légaré 2018). Additionally,
recommendations were recently provided for a Core Outcome Set
for Multimorbidity Research (COSmm) (Smith 2018).
Duration of follow-up will need to be carefully considered when in-
tervention implementation is planned, to assess the longer-term
effectiveness of new interventions for involving older patients with
multi-morbidity in decision-making when consulting in primary
care.
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Methods Study design: randomised controlled trial; assumed parallel-group design; 3 arms: 'Making the Most of
Your Health Care' intervention; 'Safety' group (attention control); usual care
Definition of multi-morbidity: at least 2 of 7 qualifying chronic illnesses as defined by International
Classification of Diseases (ICD-9) codes
Study duration: study dates not reported; 6-month follow-up period
Participants Description: patients 65 years or older with multi-morbidity (26 intervention + 27 attention control + 26
usual care)
Geographic location: study carried out in collaboration with the Scott & White Center for Diagnostic
Medicine, Temple, Texas, USA
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Setting: usual primary care clinic; patients' homes. However, staG delivering the intervention and at-
tention-based control were unlikely to be the usual care providers
Age, mean (SD): intervention group 76 (7); safety group 73 (6); usual care group 73 (5)
Number of long-term conditions, mean (SD): intervention group 3.6 (0.9); safety group 3.3 (1.0); usual
care group 3.8 (1.2)
Gender: 65.8% female
Ethnicity: 98% non-Hispanic/Latino, 92.4% white
Language: not reported (however, all included participants required to communicate in English)
Socioeconomic status: 60.6% had an annual household income of $50,000 or more
Work status: not reported
IMD for practices: not reported
Place of residence: not reported
Education: 84.6% had received at least some college education
Frailty: Charlson Commorbidity Index, mean (SD): intervention group 1.5 (1.6); safety group 1.1 (0.9);
control group 1.9 (1.6)
Mobility/functional ability: not reported (however, included participants were able to travel to the clin-
ic for a workshop)
Receipt of carer support: not reported
Communication vulnerability: not reported
Interventions Intervention name: ‘Making the Most of Your Health Care’ intervention
Intervention type: patient-focused; patient group workshop and individual coaching intervention, us-
ing evidence-based behaviour change techniques
Aims and rationale: to improve patient engagement and health-related quality of life using evi-
dence-based behaviour change techniques. Intervention components were developed using the Self-
Determination Theory of motivation. The intervention provided information, offered tools, and taught
skills to patients to prepare for healthcare appointments; communicate effectively and gather informa-
tion and support during healthcare appointments; and follow through on plans of care
Materials: participants received print copies of 'A Guide for Older People: Talking with Your Doctor,
Bound for Your Good Health'* and a list of local community resources upon arrival to the workshop.
During the workshop, content from 'A Guide for Older People: Talking with Your Doctor'* was discussed
including worksheets on "changes to discuss", "concerns", and "medications"*. Coaches utilised elec-
tronic health records. Coaching calls adhered to the 'Five As framework for behavioural counselling (as-
sess, advise, agree, assist, arrange)'
Procedures: a 2-hour workshop led by a “coach” and 2 telephone calls tailored to the patient’s pre- and
post-healthcare appointment needs. The workshop covered introduction and breaking the ice; giving
information and getting ready for appointments; getting information at appointments; and following
through after appointments. The workshop involved group discussion, visual presentation, role-play of
interactions with doctors, and individual practice. Coaches monitored participants’ upcoming health-
care appointments using electronic records and provided a brief coaching phone call within a week be-
fore a scheduled appointment and another call within a week after that appointment. Phone calls were
used to discuss the workshop content in the context of each participant’s unique circumstances
Elements related specifically to patient involvement in decision-making: the workshop topic 'Get-
ting Information at Appointments' included content on 'making decisions with your doctor', based on
guidance from the National Institute on Ageing. Groups discussed examples of barriers to shared deci-
sion-making
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Mode of delivery: face-to-face group workshops; at-a-distance phone calls with individuals
Who delivered the intervention?
Health "coaches" delivered workshops and telephone calls. No further details were provided on the
background or qualifications of the health coaches - assumed members of the research team
Where was the intervention provided?
Workshops were delivered at the patient's usual primary care clinic (a large internal medicine clinic).
Assumed patients contacted on personal telephones for coaching calls, presumably in own homes, al-
though not explicitly stated
When and how often or how much of the intervention was provided?
Three contacts: 1 workshop and 2 coaching telephone calls. Appointments were tracked for up to 3
months after baseline. Within 5 days before (pre-appointment call) and 5 days after (follow-up call),
coaches contacted participants by telephone for sessions that lasted approximately 15 minutes. Work-
shops were offered at convenient times
Was the intervention tailored?
Coaching phone calls were tailored to the context of each participant's unique circumstances
Was the intervention modified or adapted?
No modifications or adaptations were reported
Outcomes High self-rated health
Tool: the 'Healthy Days Measure' (CDC 2000) 5-point scale; higher scores = higher self-rated health
Review category: health status
Timing of measurement: baseline and at 6 months
Patient activation
Tool: patient self-report using the Patient Activation Measure (Hibbard 2005); scale 0 to 100; higher
score = greater patient activation
Review category: patient enablement and engagement
Timing of measurement: baseline and at 6 months
Number of outpatient/clinic visits
Tool/measure not reported
Review category: resource use and cost
Timing of measurement: baseline and at 6 months
Control or usual care Usual care: primary care within a large internal medicine clinic
Control: attention-control condition (safety group): patient-focused; employed the same types and
numbers of contacts as the intervention. The topic of the safety contacts was “general safety for older
adults”, and content included arranging the home environment to avoid falls and fire risks, identifying
theQ, and discussing caregiver stress
Funding source and poten-
tial conflicts of interest
Funding: the study was supported by a grant from the Scott & White Healthcare Research Foundation
Potential conflicts of interest: insufficient information reported
Notes *National Institute on Aging publications
Other outcomes, considered of less relevance to the review:
Communication with physicians scale
Total unhealthy days
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Unhealthy mental days
Unhealthy physical days
Self-efficacy for managing chronic disease measure
Number of emergency department visits
Number of hospitalisations
Nights spent in the hospital
Number of chronic illness diagnoses
Charlston Comorbidity Index
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation using computer software
"The randomization schedule was generated using SAS version 9.1.2 (SAS In-
stitute Inc., Cary, NC) with an equal proportion assigned to each of the three
groups in the master list"
Allocation concealment
(selection bias)
Low risk Randomisation occurred after enrolment; central allocation was used
"Following baseline, a study coordinator who also served as a coach requested
group assignment from the biostatistics office for each participant"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Assumed blinding was not possible in all cases due to the nature of the inter-
vention; however, it is unclear whether this could have affected outcomes
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Telephone interviewers were blinded, but it is not stated whether or not ex-
tracting data from EHRs involved "telephone interviews [were] conducted by a
research assistant who was blinded to group assignment"
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Some imbalance between groups but not enough to class as high-risk. ITT
analysis
Selective reporting (re-
porting bias)
Unclear risk Unable to find the protocol or trial registration
Other bias Low risk No other obvious sources of bias
Hochhalter 2010  (Continued)
 
 
Methods Study design: randomised controlled trial; parallel-group design; 2 arms: 'chronic disease self-manage-
ment support' (CDSMS) intervention; 'positive attention' control
Definition of multi-morbidity: 2 or more of 8 types of chronic conditions identified as Australian Nation-
al Health priority areas but with the addition of several chronic conditions that are frequently managed
in Australian general practice
Study duration: September 2009 to June 2010; 6-month follow-up period
Participants Description: patients at least 60 years old with multi-morbidity (127 + 127)
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Geographical location: Adelaide, Australia
Setting: general practice, patient's home. Research set up with no direct contact between providers
and participants' usual GPs or other healthcare providers
Age: CDSMS group: 48% aged 60 to 75, 36% aged 76 to 85, 16% aged > 85; control group: 46% aged 60 to
75, 40% aged 76 to 85, 14% aged > 85
Number of long-term conditions (S): CDSMS group 4.4 (0.11); control group 4.5 (0.12)
Gender: CDSMS group 59% women; control group 61% women
Country of birth: CDSMS group: Australia 76%, Ireland or United Kingdom 14%, Europe 9%, Other 1%;
control group: Australia 76%, Ireland or United Kingdom 13%, Europe 8%, Other 2%
Language: not reported; however, all eligible participants spoke English
Socioeconomic status: household income CDSMS group: $0 to 20,000 29%, $20,001 to 40,000 44%, >
$40,000 22%; missing data: 6%; household income control group: $0 to 20,000 31%, $20,001 to 40,000
47%, > $40,000 17%; missing data: 6%
Work status: CDSMS group: 85% retired from employment, 9% home duties, 6% other; control group:
85% retired from employment, 10% home duties, 5% other
IMD for practices: not reported
Place of residence: not explicitly reported but those residing in a long-term care facility were excluded
Education: CDSMS group: 39% leQ school age 15 or earlier, 61% leQ school after age 15; control group:
49% leQ school age 15 or earlier, 51% leQ school after age 15
Frailty: not reported
Mobility/functional ability: not reported
Receipt of carer support: not reported
Communication vulnerability: not reported
Interventions Intervention name: Chronic Disease Self-Management Support (CDSMS) programme
Intervention type: patient-focused; an individual patient coaching intervention, utilising cognitive-be-
havioural therapy (CBT) and motivational interviewing (MI)
Aims and rationale: based on the Flinders Chronic Condition Management Programme (Battersby
2007), the CDSMS programme is designed to be a structured intervention based on cognitive-behav-
ioural therapy and motivational interviewing, with the aim of achieving sustained behaviour change for
patients by increasing patients’ skills and confidence in managing their chronic diseases. Theoretical
reasons for utilising CDSMS for older people with multi-morbidity are reported: (1) complexity of infor-
mation and treatment regimens, and (2) need for priority setting
Materials: 3 standardised assessment and planning tools, designed to actively assist participants to
achieve actions and goals and to develop and review a care plan: ‘Partners in Health Scale’; ‘Cue and
Response Interview’; ‘Problems and Goals Assessment’
Procedures: a structured process to enable clinicians and patients to collaboratively assess self-man-
agement behaviour, identify problems, set goals, and develop individual care plans that address self-
care, medical, psychosocial, and carer problems. The health professional's role is to facilitate goal-set-
ting and to act as coach and advisor. The participant's role is in active decision-making in collaboration
with the health professional. The ‘Partners in Health Scale’ is used first, the ‘Cue and Response Inter-
view’ is then used to collaboratively identify problems and motivate behaviour change, and the ‘Prob-
lems and Goals Assessment’ is then used to identify goals; finally, a care plan is written
Reed 2018  (Continued)
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Elements related specifically to patient involvement in decision-making: facilitated goal-setting; active
decision-making in collaboration and care plan development and review between patient and health
professional
Mode of delivery: a combination of paper-based, face-to-face, and over-the-phone delivery
Who delivered the intervention?
Clinical staG, with qualifications in nursing or psychology and associated with the research team, deliv-
ered the intervention. There was no direct contact between these staG and participants’ GPs or other
healthcare providers. Ongoing mentoring from accredited trainers was available to clinicians deliver-
ing the CDSMS and control programmes. Participants continued taking routine medications and visit-
ing their usual primary care physician throughout the study
Where was the intervention provided?
Patients’ homes, metropolitan Adelaide, South Australia
When and how often or how much of the intervention was provided?
Participants in each programme received 3 home visits and 4 follow-up phone calls over a 6-month pe-
riod
Was the intervention tailored?
Care plans were individualised
Was the intervention modified or adapted?
No modifications or adaptations were reported
Outcomes Self-rated health
Tool: 5-point scale initially developed for the US National Health and Nutrition Examination Survey;
higher scores = higher self-rated health
Review category: health status
Timing of measurement: baseline and at 6 months
Self-efficacy
Tool: Patient self-report using the self-efficacy for managing chronic disease scale (Stanford 2018);
higher scores = higher self-efficacy
Review category: patient enablement and engagement
Timing of measurement: baseline and at 6 months
(Review authors have calculated the SD from the SE for this outcome)
Patient reports of whether the programme changed management of their health conditions
Tool: patient self-report via questionnaire using a 3-point scale; higher score = higher perception of
changed management
Review category: patient evaluation of care/the intervention
Timing of measurement: baseline and at 6 months
Numbers of general practice visits during the preceding 6 months
Tool: patient self-report via questionnaire
Review category: resource use and cost
Timing of measurement: baseline and at 6 months
(Review authors have calculated the SD from the SE for this outcome)
Control or usual care Control: attention-control condition: patient-focused.
The comparator group was chosen to control for the positive benefits of receiving attention from a
health professional. The semi-structured approach, delivered by clinical staG associated with the re-
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search team, provided health information, non-directive counselling, and supportive listening. The ap-
proach used no assessment or self-management tools; however, personalised health information was
provided to facilitate health-related conversations. The clinician’s role was to provide positive atten-
tion. The participant's role was to passively receive health information and to participate in informal
conversations
Provided in patients' homes, metropolitan Adelaide, South Australia
Participants in each programme received 3 home visits and 4 follow-up phone calls over a 6-month pe-
riod
Funding source and poten-
tial conflicts of interest
Funding: Australian Department of Health and Ageing (DoHA) under the Sharing Health Care Initiative -
Innovations in Chronic Disease Self-Management Research Grants programme
Potential conflicts of interest:
Richard Osborne was supported in part by a National Health and Medical Research Council Population
Health Research Fellowship (Career Development Award)
Malcolm Battersby is the developer of the Flinders Program but declares no financial interest
Notes Other outcomes, considered of less relevance to the review:
Health status: fatigue
Health status: pain
Health status: health distress
Health status: energy
Health status: depression
Health status: illness intrusiveness
Health behaviours: exercise
Health behaviours: medication adherence
Numbers of emergency department visits
Numbers of hospital admissions
Rating of usefulness of the programme
Whether the program improved patients' relationship with their GP
Whether patients would recommend the programme to other patients
Perceived usefulness of the programme in improving patients' health
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation sequence
Allocation concealment
(selection bias)
Low risk Central allocation after baseline
"A printed record of the allocation sequence was retained by an independent,
centrally located hospital pharmacy … carried out after the baseline inter-
view"
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Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk Incomplete blinding (participants but not research personnel), but the review
authors judge that the outcome is not likely to be influenced by lack of blind-
ing
"Participants provided written, informed consent for participation; they were
blinded to their allocation, but the investigators were not"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Insufficient information to permit judgement of ‘low risk’ or ‘high risk’
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Attrition was balanced. ITT analysis; method of imputation reported
"The analyses were intention-to-treat analyses; missing data were imputed ac-
cording to the baseline-value-carried-forward method"
Selective reporting (re-
porting bias)
Low risk The study protocol is available, and all of the study’s pre-specified (primary
and secondary) outcomes that are of interest in the review have been reported
in the pre-specified way
Other bias Low risk No other obvious sources of bias
Reed 2018  (Continued)
 
 
Methods Study design: cluster-randomised controlled trial; 2 arms: '3D' intervention; usual care. Clusters at
practice level. Allocations were made in blocks of 2 per area, with an intervention and a control prac-
tice allocated simultaneously
Definition of multi-morbidity: at least 3 types of chronic conditions from a list of 11 compiled by group-
ing the 17 chronic conditions included in the UK Quality and Outcomes Framework (QOF) pay-for-per-
formance programme into types of conditions with similar management considerations
Study duration: March 2014 to September 2017; 15-month follow-up period
Participants Description: patients with multi-morbidity (797 + 749) from 33 practices: 16 intervention practices, 17
usual care practices
Geographical location: Bristol and Greater Manchester in England, and Ayrshire in Scotland
Setting: GP surgeries providing National Health Service (NHS) primary medical care. Patients' usual
general practice and usual primary care providers
Age, mean (SD): intervention group 71.0 (11.6), control group 70.7 (11.4)
Number of long-term conditions (SD): 3.2 (0.5)
Gender: intervention group female 51%; control group female 50%
Ethnicity: intervention group: white 99%; other or unknown 1%; control group: white 99%; other or un-
known 1%
Language: no English language was an exclusion criterion; no further details provided
Socioeconomic status: intervention group fully retired from work 71%; control group fully retired from
work 69%
IMD for practices: intervention group: English 15.6 (9.6), n = 11, Scottish 24.2 (20.0), n = 5; control group:
English 15.8 (12.2), n = 12, Scottish 26.4 (18.3), n = 5
Place of residence: not reported
Education: not reported
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Frailty: not reported
Mobility/functional ability: not explicitly reported; however, some aspects captured in ‘health-related
quality of life’ measure
Receipt of carer support: not reported
Communication vulnerability: some likely to have been excluded by eligibility criteria; however, 1% of
both groups had a learning disability and 4% of both groups had dementia
Interventions Intervention name: the ‘3D’ intervention
Intervention type: patient-focused, practitioner-focused, and related to organisational change; a com-
prehensive, holistic intervention, utilising multi-disciplinary practitioner training and organisational
change with the aim to maximise continuity, co-ordination, and efficiency of care
Aims and rationale: a patient-centred care model, encapsulating strategies recommended in recent
international guidelines (ref), replacing disease-focused review of each health condition with one 6-
monthly comprehensive multi-disciplinary review. The 3D intervention has the aim of improving conti-
nuity, co-ordination, and efficiency of care for patients with multi-morbidity. Using the 3D review, study
authors seek to address the burden of treatment for patients with multi-morbidity. Study authors re-
port that if each condition is considered in isolation, patients can be prescribed numerous drugs and
lifestyle changes, and are expected to attend frequent healthcare appointments
Materials: an electronic template integrated within the EMIS electronic medical records system rein-
forces the patient-centred approach and is interactive, with prompts for clinicians that change depend-
ing on the patient’s combination of chronic conditions. In addition, an appointment letter asked the
patient to think about the health problems that bother them most, and patients were provided with a
3D wallet card, naming their responsible doctor
Procedures: each 3D review consists of 2 appointments (a nurse appointment and a named responsi-
ble physician appointment) and a records-based medication review by a pharmacist. “The nurse focus-
es on identifying the health problems most important to the patient; asking about pain, function, and
quality of life; screening for depression and dementia; and then addressing the disease-specific care
the patient requires. Findings are printed as a patient-held agenda to inform the subsequent consulta-
tion with the doctor. The pharmacist uses the patient’s electronic medical records to review medica-
tion, and makes recommendations about simplifying and optimising treatment. The physician consid-
ers the nurse and pharmacist reviews, discusses treatment adherence, and agrees on a collaborative
health plan with the patient. The patient is given a printed copy of the plan, which specifies how the pa-
tient and clinicians will address the agreed goals over the next 6 months through routine consultation-
s" (Procedures, pp 43-44)
Elements related specifically to patient involvement in decision-making: training sessions with clin-
icians included how to identify patients’ priorities and agree on a health plan with patients that was
‘SMART’ (Specific; Measurable; Achievable; Realistic; Time-bound). The 3D review seeks to identify the
health problems of most importance to the patient, along with additional problems from the clinician’s
point of view. All problems are shared with the patient after the first consultation in an ‘agenda’ docu-
ment, to encourage collaboration. During a subsequent GP consultation, a holistic, collaborative plan
is made to address the agenda, guided by the patient’s top 4 priorities for action. This health plan is
documented and printed as the result of an agreed, negotiated discussion
Mode of delivery: assumed patients sent appointment letter by post. Location of patient appointments
not recorded but assumed face-to-face. Medication reviews records-based and not appearing to involve
patients directly
Who delivered the intervention?
Each practice identified a local champion to support implementation. At practice level, changes were
made to flag patients with multi-morbidity in electronic medical records systems; promote continuity
of care; provide a 3D wallet card for patients, naming the responsible doctor; encourage patients to ask
for longer appointments when needed; train clinicians and receptionists; replace separate disease-fo-
cused reviews with one 6-monthly whole-person 3D review; and implement an interactive 3D electronic
data entry template. Each patient was allocated a usual responsible GP and nurse, who would conduct
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the 3D reviews. All practice clinical staG involved in delivering the intervention received 2 half-days of
training. Administrative staG were trained in a separate meeting
Where was the intervention provided?
The intervention was delivered at the patient's usual GP practice
When and how often or how much of the intervention was provided?
The intention was for patients to receive 2 3D reviews within a 12-month period, with reviews carried
out every 6 months
Was the intervention tailored?
Disease-specific questions and prompts (presented to clinicians via the electronic template) varied de-
pending on the patient's combination of conditions
Was the intervention modified or adapted?
The intervention was not modified nor adapted
Outcomes Health-related quality of life
Tool: patient self-report using the EQ-5D-5L measure (Herdman 2011); higher scores = higher perceived
quality of life
Review category: health status
Timing of measurement: baseline, at 9 months (data not extracted), and at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Treatment burden
Tool: patient self-report using the Multi-morbidity Treatment Burden Questionnaire (MTBQ) (Duncan
2018); higher score = higher perceived burden
Review category: treatment burden
Timing of measurement: baseline, at 9 months (data not extracted), and at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Medication adherence
Tool: patient self-report using the Morisky Medication Adherence Scale (Morisky 2008); higher score =
greater adherence
Review category: patient enablement and engagement
Timing of measurement: baseline and at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Patient-centred care: proportion who discussed the problems most important to them
Tool: patient self-report using a single question and a 5-point scale, adapted from the General Practice
Patient Survey (Ipsos MORI 2015); higher score = higher perception of discussing priorities
Review category: patient evaluation of care/the intervention
Timing of measurement: baseline, at 9 months (data not extracted), and at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Carer experience
Tool: carer self-report using a 6-item carer experience questionnaire (Al-Janabi 2011); score 0 to 100;
higher scores = better experience with the health care provided
Review category: patient and carer outcomes
Timing of measurement: baseline and at 15 months
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(Results have been recalculated for analysis using data as presented in the trial report)
Number of consultations in primary care: nurse
Tool: routine review of medical records by the research team
Review category: resource use and cost
Timing of measurement: baseline and at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Number of indicators of high-risk prescribing
Tool: review of routine electronic health records using an approach developed for a previous trial
(Dreischulte 2016)
Review category: quality of care
Timing of measurement: at 15 months
(Results have been recalculated for analysis using data as presented in the trial report)
Control or usual care Usual care. In UK, mainly consists of: nurse-led disease-specific chronic disease reviews focused on
meeting the outcomes of the UK Quality and Outcomes Framework pay-for-performance scheme
Funding source and poten-
tial conflicts of interest
Funding: National Institute for Health Research, Health Services and Delivery Research programme,
project number 12/130/15
Potential conflicts of interest:
One study author is a member of the NIHR Health Services and Delivery Research Board
Another study author chairs the Guideline Development Group of the National Institute for Health and
Clinical Excellence (NICE) Multimorbidity Clinical Guideline NG56 and was a member of the NIHR Health
Services and Delivery Research researcher-led panel
All other study authors declared no competing interests
Notes Other outcomes, considered of less relevance to the review:
Burden of illness: self-rated health
Burden of illness: how much illness affects the individual's life
Burden of illness: anxiety
Burden of illness: depression
Polypharmacy: number of different drugs prescribed in last 3 months
Patient-centred care: doctor
Patient-centred care: nurse
Patient-centred care: proportion experiencing care as joined up
Patient-centred care: proportion having written a care plan, health plan, or treatment plan
Satisfaction with care
Continuity of care: Continuity of Care Index
Discontinuity of care: Visit Entropy measure
Number of consultations in primary care: physician
Number of consultations and secondary care: hospital admissions
Number of consultations and secondary care: outpatient attendance
Additional cost-effectiveness data
Quality of disease management: proportion of applicable QOF chronic disease targets met
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Qualitative process assessment (reported elsewhere)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Sequence generation appears sufficient to ensure random assignment of par-
ticipants
"The randomisation system was run from the Bristol Randomised Trials Col-
laboration by the trial statistician, who was masked to practice identifiers. Al-
locations were done in blocks of two in each area, with an intervention and a
control practice allocated simultaneously"
Allocation concealment
(selection bias)
Low risk Randomisation carried out after practice recruitment
"Patients were assessed for eligibility and invited to participate before prac-
tice allocation, and were not informed of their practice’s allocation until they
had given consent and completed baseline measures. ... The randomisation
system was run from the Bristol Randomised Trials Collaboration by the trial
statistician, who was masked to practice identifiers. Allocations were done in
blocks of two in each area, with an intervention and a control practice allocat-
ed simultaneously so that concealment of allo cation was maintained"
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not done. Some potential for this to influence outcomes but not clear if this
occurred
"Because of the nature of the intervention, practices and participants were
aware of their treatment allocation"
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Some blinding/automation but not for all outcomes
"Outcome data were selfreported or based on automated extraction of data
from the electronic medical records, except for details of hospital use, which
were collected manually by researchers who were aware of practice alloca-
tion. Analysis was done by the trial statistician (DG), who was masked to allo-
cation, except for details of healthcare use, for which masking could not be
maintained"
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Intention-to-treat analysis; attrition not reported; lack of data for some items
and some imbalance between groups but not enough to be classed as high
risk; method of imputation reported (for the primary outcome)
"We used multiple imputation by chain equations including baseline, 9month,
15month, and EQ5D5L data as available, intervention group, stratification and
minimisation variables, and other covariates that were informative of missing-
ness"
Selective reporting (re-
porting bias)
Low risk Protocol available. All pre-specified outcomes reported either in the paper or
in the full report
Other bias Low risk Selective recruitment of cluster participants:
Cluster participants were recruited before group assignment, and the same
participants were followed up over time; therefore low risk of selective recruit-
ment of cluster participants; no other obvious sources of bias
"Patients were assessed for eligibility and invited to participate before practice
allocation"
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3D: intervention that was both patient- and practitioner-focused and addressed organisational change.
CBT: cognitive-behaviour therapy.
CDSMS: Chronic Disease Self-Management Support programme.
EHR: electronic health record.
EQ-5D-5L: EuroQoL Group Quality of Life Questionnaire based on a five-level scale.
GP: general practitioner.
IMD: XXX.
ITT: intention-to-treat.
MI: motivational interview.
MTBQ: Multi-morbidity Treatment Burden Questionnaire.
NHS: National Health Service.
NICE: National Institute for Health and Care Excellence.
QOF: Quality and Outcomes Framework.
SD: standard deviation.
SE: standard error.
SMART: Specific; Measurable; Achievable; Realistic; Time-bound plan,
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Alkema 2007 Wrong setting
Beck 2013 Wrong intervention
Berglund 2013 Wrong setting
Berglund 2015 Wrong setting
Bernabei 1998 Wrong setting
Bielaszka-DuVernay 2011 Wrong intervention
Blom 2016 Wrong patient population
Bosma 2011 Wrong patient population
Boult 2008 Wrong intervention
Boult 2011a Wrong intervention
Boult 2011b Wrong intervention
Boult 2013 Wrong intervention
Boyd 2007 Wrong intervention
Boyd 2008 Wrong intervention
Caughey 2017 Wrong setting
Cheema 2017 Wrong intervention
Cheng 2018 Wrong patient population
Chi-Jane 2013 Wrong intervention
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Study Reason for exclusion
Chow 2014 Wrong setting
Coburn 2012 Wrong patient population
Dorr 2008 Wrong intervention
Dowrick 2018 Wrong study design
Dye 2018 Wrong intervention
Elzen 2007 Wrong patient population
Engelhardt 2009 Wrong patient population
Fortin 2016 Wrong patient population
Freund 2011 Wrong setting
Fried 2017 Wrong study design
Ganz 2010 Wrong patient population
Glaser 2017 Wrong patient population
Hanlon 1996 Wrong intervention
Harrison 2012 Wrong patient population
Ivey 2018 Wrong patient population
Jerant 2009 Wrong patient population
Joos 1996 Wrong setting
Junius-Walker 2012 Wrong patient population
Kangovi 2017 Wrong patient population
Kennedy 2013 Wrong patient population
Kim 2017 Wrong intervention
Lin 2012 Wrong patient population
LudmanEvette 2013 Wrong patient population
Légaré 2015 Wrong patient population
Markle-Reid 2018 Wrong setting
Panagioti 2018 Wrong intervention
Sudore 2017 Wrong patient population
Valdivieso 2018 Wrong intervention
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
54
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study Reason for exclusion
Von 2011 Wrong patient population
Wetzels 2005 Wrong patient population
Willeboordse 2017 Wrong patient population
Wissow 2004 Wrong patient population
Wrede 2013 Wrong patient population
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Goal-setting in care planning for people with multi-morbidity
Methods Cluster-randomised controlled feasibility trial of goal-setting compared with control in 6 general
practices
Participants Adults with 2 or more long-term health conditions and at risk of unplanned hospital admission
Interventions General practitioners (GPs) undergo training and patients are asked to consider goals before an ini-
tial goal-setting consultation and a follow-up consultation 6 months later. The control group re-
ceives usual care planning
Outcomes Health-related quality of life (EQ-5D-5L), capability (ICEpop CAPability measure for Older people),
Patient Assessment of Chronic Illness Care and healthcare use
Starting date March 2015
Contact information n.steel@uea.ac.uk
Notes  
Steel 2016 
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Comparison 1.   Interventions for involving patients in decision-making about their health care vs usual care for
older patients with multi-morbidity
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Health status: high self-rated health (CDC 'Healthy Days
Measure') at 6 months
1 41 Risk Ratio (M-H, Random,
95% CI)
1.4 [0.36,
5.49]
2 Health status: health-related quality of life (EQ-5D-5L mea-
sure) at 15 months
1 1546 Mean Difference (Ran-
dom, 95% CI)
0.0 [-0.02,
0.02]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3 Treatment burden (Multi-morbidity Treatment Burden
Questionnaire) at 15 months
1 1251 Mean Difference (Ran-
dom, 95% CI)
-0.46 [-1.78,
0.86]
4 Patient enablement and engagement: patient activation
(Patient Activation Measure) at 6 months
1 41 Mean Difference (IV, Ran-
dom, 95% CI)
0.60 [-9.23,
10.43]
5 Patient enablement and engagement: medication adher-
ence (Morisky Medication Adherence Scale) at 6 months
1 1546 Mean Difference (Fixed,
95% CI)
0.06 [-0.05,
0.17]
6 Patient evaluation of care/the intervention: care related to
priorities (adapted question from General Practice Patient
Survey) at 15 months
1 1211 Odds Ratio (Random,
95% CI)
1.85 [1.44,
2.38]
7 Carer evaluation of care: carer experience (Carer Experi-
ence Questionnaire) at 15 months
1 94 Mean Difference (Ran-
dom, 95% CI)
6.51 [0.25,
12.77]
8 Resource use and cost: number of nurse consultations (re-
view of medical records) at 15 months
1 1517 Rate Ratio (Random, 95%
CI)
1.37 [1.17,
1.61]
9 Quality of care: number of indicators of high-risk prescrib-
ing (review of medical records) at 15 months
1 1521 Rate Ratio (Random, 95%
CI)
1.04 [0.87,
1.25]
 
 
Analysis 1.1.   Comparison 1 Interventions for involving patients in decision-making
about their health care vs usual care for older patients with multi-morbidity, Outcome
1 Health status: high self-rated health (CDC 'Healthy Days Measure') at 6 months.
Study or subgroup Intervention Usual care Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Hochhalter 2010 4/20 3/21 100% 1.4[0.36,5.49]
   
Total (95% CI) 20 21 100% 1.4[0.36,5.49]
Total events: 4 (Intervention), 3 (Usual care)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.48(P=0.63)  
Favours [usual care] 200.05 50.2 1 Favours [intervention]
 
 
Analysis 1.2.   Comparison 1 Interventions for involving patients in decision-making
about their health care vs usual care for older patients with multi-morbidity, Outcome
2 Health status: health-related quality of life (EQ-5D-5L measure) at 15 months.
Study or subgroup Inter-
vention
Usual care Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 797 749 0 (0.01) 100% 0[-0.02,0.02]
   
Total (95% CI)       100% 0[-0.02,0.02]
Favours intervention 2010-20 -10 0 Favours control
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Study or subgroup Inter-
vention
Usual care Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours intervention 2010-20 -10 0 Favours control
 
 
Analysis 1.3.   Comparison 1 Interventions for involving patients in decision-making
about their health care vs usual care for older patients with multi-morbidity, Outcome
3 Treatment burden (Multi-morbidity Treatment Burden Questionnaire) at 15 months.
Study or subgroup Inter-
vention
Usual care Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 625 626 -0.5 (0.674) 100% -0.46[-1.78,0.86]
   
Total (95% CI)       100% -0.46[-1.78,0.86]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.68(P=0.49)  
Favours intervention 2010-20 -10 0 Favours control
 
 
Analysis 1.4.   Comparison 1 Interventions for involving patients in decision-making about
their health care vs usual care for older patients with multi-morbidity, Outcome 4 Patient
enablement and engagement: patient activation (Patient Activation Measure) at 6 months.
Study or subgroup Intervention Usual care Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Hochhalter 2010 20 66.8 (18.5) 21 66.2 (13) 100% 0.6[-9.23,10.43]
   
Total *** 20   21   100% 0.6[-9.23,10.43]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.12(P=0.9)  
Favours [usual care] 2010-20 -10 0 Favours [intervention]
 
 
Analysis 1.5.   Comparison 1 Interventions for involving patients in decision-making about their
health care vs usual care for older patients with multi-morbidity, Outcome 5 Patient enablement
and engagement: medication adherence (Morisky Medication Adherence Scale) at 6 months.
Study or subgroup Inter-
vention
Usual care Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
Salisbury 2018 797 749 0.1 (0.056) 100% 0.06[-0.05,0.17]
   
Total (95% CI)       100% 0.06[-0.05,0.17]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.07(P=0.28)  
Favours intervention 2010-20 -10 0 Favours control
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Analysis 1.6.   Comparison 1 Interventions for involving patients in decision-making about their health
care vs usual care for older patients with multi-morbidity, Outcome 6 Patient evaluation of care/the
intervention: care related to priorities (adapted question from General Practice Patient Survey) at 15 months.
Study or subgroup Inter-
vention
Usual care log[Odds
Ratio]
Odds Ratio Weight Odds Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 612 599 0.6 (0.128) 100% 1.85[1.44,2.38]
   
Total (95% CI)       100% 1.85[1.44,2.38]
Heterogeneity: Not applicable  
Test for overall effect: Z=4.81(P<0.0001)  
Favours control 200.05 50.2 1 Favours intervention
 
 
Analysis 1.7.   Comparison 1 Interventions for involving patients in decision-making about
their health care vs usual care for older patients with multi-morbidity, Outcome 7 Carer
evaluation of care: carer experience (Carer Experience Questionnaire) at 15 months.
Study or subgroup Inter-
vention
Usual care Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 39 55 6.5 (3.194) 100% 6.51[0.25,12.77]
   
Total (95% CI)       100% 6.51[0.25,12.77]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.04(P=0.04)  
Favours control 2010-20 -10 0 Favours intervention
 
 
Analysis 1.8.   Comparison 1 Interventions for involving patients in decision-making about
their health care vs usual care for older patients with multi-morbidity, Outcome 8 Resource
use and cost: number of nurse consultations (review of medical records) at 15 months.
Study or subgroup Inter-
vention
Usual care log[Rate
Ratio]
Rate Ratio Weight Rate Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 778 739 0.3 (0.081) 100% 1.37[1.17,1.61]
   
Total (95% CI)       100% 1.37[1.17,1.61]
Heterogeneity: Not applicable  
Test for overall effect: Z=3.89(P=0)  
Favours intervention 200.05 50.2 1 Favours control
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Analysis 1.9.   Comparison 1 Interventions for involving patients in decision-making about
their health care vs usual care for older patients with multi-morbidity, Outcome 9 Quality of
care: number of indicators of high-risk prescribing (review of medical records) at 15 months.
Study or subgroup Inter-
vention
Usual care log[Rate
Ratio]
Rate Ratio Weight Rate Ratio
  N N (SE) IV, Random, 95% CI   IV, Random, 95% CI
Salisbury 2018 780 741 0 (0.093) 100% 1.04[0.87,1.25]
   
Total (95% CI)       100% 1.04[0.87,1.25]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.45(P=0.65)  
Favours intervention 200.05 50.2 1 Favours control
 
 
Comparison 2.   Interventions for involving patients in decision-making about their health care vs attention-control
conditions for older patients with multi-morbidity
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Health status: high self-rated health (CDC 'Healthy Days Mea-
sure' and another similar 5-point scale, dichotomised) at 6
months
2   Risk Ratio (M-H, Ran-
dom, 95% CI)
Totals not
selected
2 Patient enablement and engagement: patient activation (Pa-
tient Activation Measure) at 6 months
1 43 Mean Difference (IV,
Random, 95% CI)
1.20 [-8.21,
10.61]
3 Patient enablement and engagement: self-efficacy (Self-Effi-
cacy for Managing Chronic Disease Scale) at 6 months
1 254 Mean Difference (IV,
Random, 95% CI)
0.29 [-0.21,
0.79]
4 Patient evaluation of care/the intervention: changed man-
agement of their health (patient self-report, 3-point scale di-
chotomised) at 6 months
1 231 Risk Ratio (M-H, Ran-
dom, 95% CI)
1.82 [1.35,
2.44]
5 Resource use and cost: number of general practice visits (pa-
tient self-report via questionnaire) at 6 months
1 254 Mean Difference (IV,
Random, 95% CI)
0.51 [-0.34,
1.36]
 
 
Analysis 2.1.   Comparison 2 Interventions for involving patients in decision-making about their health care
vs attention-control conditions for older patients with multi-morbidity, Outcome 1 Health status: high self-
rated health (CDC 'Healthy Days Measure' and another similar 5-point scale, dichotomised) at 6 months.
Study or subgroup Intervention Attention Control Risk Ratio Risk Ratio
  n/N n/N M-H, Random, 95% CI M-H, Random, 95% CI
Hochhalter 2010 4/20 12/23 0.38[0.15,1]
Reed 2018 13/127 6/127 2.17[0.85,5.52]
Favours [att. control] 200.05 50.2 1 Favours [intervention]
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Analysis 2.2.   Comparison 2 Interventions for involving patients in decision-making about their
health care vs attention-control conditions for older patients with multi-morbidity, Outcome 2
Patient enablement and engagement: patient activation (Patient Activation Measure) at 6 months.
Study or subgroup Intervention Attention Con-
trol Group
Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Hochhalter 2010 20 66.8 (18.5) 23 65.6 (11.7) 100% 1.2[-8.21,10.61]
   
Total *** 20   23   100% 1.2[-8.21,10.61]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.25(P=0.8)  
Favours [control] 2010-20 -10 0 Favours [intervention]
 
 
Analysis 2.3.   Comparison 2 Interventions for involving patients in decision-making about their
health care vs attention-control conditions for older patients with multi-morbidity, Outcome 3 Patient
enablement and engagement: self-e:icacy (Self-E:icacy for Managing Chronic Disease Scale) at 6 months.
Study or subgroup Intervention Attention Con-
trol Group
Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Reed 2018 127 6.6 (2.1) 127 6.3 (1.9) 100% 0.29[-0.21,0.79]
   
Total *** 127   127   100% 0.29[-0.21,0.79]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.14(P=0.26)  
Favours [att. control] 2010-20 -10 0 Favours [intervention]
 
 
Analysis 2.4.   Comparison 2 Interventions for involving patients in decision-making about their health care vs
attention-control conditions for older patients with multi-morbidity, Outcome 4 Patient evaluation of care/the
intervention: changed management of their health (patient self-report, 3-point scale dichotomised) at 6 months.
Study or subgroup Intervention Attention
Control Group
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Reed 2018 69/114 39/117 100% 1.82[1.35,2.44]
   
Total (95% CI) 114 117 100% 1.82[1.35,2.44]
Total events: 69 (Intervention), 39 (Attention Control Group)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=3.95(P<0.0001)  
Favours [att. control] 200.05 50.2 1 Favours [intervention]
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Analysis 2.5.   Comparison 2 Interventions for involving patients in decision-making about their health
care vs attention-control conditions for older patients with multi-morbidity, Outcome 5 Resource
use and cost: number of general practice visits (patient self-report via questionnaire) at 6 months.
Study or subgroup Intervention Attention Con-
trol Group
Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
Reed 2018 127 5.3 (3.7) 127 4.8 (3.2) 100% 0.51[-0.34,1.36]
   
Total *** 127   127   100% 0.51[-0.34,1.36]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.18(P=0.24)  
Favours [intervention] 2010-20 -10 0 Favours [att. control]
 
 
A D D I T I O N A L   T A B L E S
 
Systematic
review
Structure Processes Outcomes
Interventions
for improving
outcomes in
patients with
multi-morbid-
ity in primary
care and com-
munity set-
tings (Smith
2016)
Smith 2016 excluded interventions that
included people with comorbid condi-
tions when the intervention was target-
ed solely at 1 condition. We will include
studies in which older people with mul-
ti-morbidity were exposed to an interven-
tion to facilitate patient involvement in
their health care, and in which outcomes
were reported with respect to this pop-
ulation, even if the intervention was not
originally designed for older patients with
multi-morbidity
Smith 2016 did not design its search
strategy to find studies of interven-
tions to facilitate the involvement of
older patients with multi-morbidity
in decision-making about their care,
which is the aim of our review.
Smith 2016 was not specifically in-
terested in the processes within, and
supporting, a general practice con-
sultation, which is the focus of our re-
view
Our review will differ from
Smith 2016 in terms of our
primary outcome of whether
or not patient involvement in
the decision-making process
occurred during a consulta-
tion, was not a primary out-
come, or was a specific fo-
cus of a secondary outcome.
Smith 2016 excluded the out-
comes of attitude and knowl-
edge when reporting stud-
ies, both of which are high-
ly relevant to the delivery of
patient-centred care, and to
patient involvement in de-
cision-making about their
health care during a primary
care consultation. Our review
will include these outcomes
to inform clinicians and pol-
icy makers about interven-
tions supporting improved
patient knowledge of their
conditions and treatments,
improved patient enable-
ment for self-care, positive
changes in patients’ health
beliefs and lifestyle choic-
es, patient satisfaction with
health care and trust in the
practitioner, and improved
practitioner communication
skills including shared deci-
sion-making. Attitudes to-
wards the intervention and
Table 1.   Comparison of our proposed review with existing systematic reviews of similar interventions 
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compliance with it will also
be important in the develop-
ment of future interventions
to facilitate the involvement
of older patients with mul-
ti-morbidity in decision-mak-
ing about their health care
Interventions
for providers
to promote a
patient-cen-
tred approach
in clinical con-
sultations
(Dawmena
2012)
Dawmena 2012 included studies of in-
terventions facilitating shared deci-
sion-making; however, this study focuses
only on studies of interventions directed
at healthcare professionals, or at health-
care professionals and patients togeth-
er. Our review would additionally include
studies of interventions targeting only pa-
tients, in particular, the very important
and vulnerable patient population of old-
er patients with multi-morbidity
- -
Personalised
care plan-
ning for adults
with chronic
or long-term
health condi-
tions (Coulter
2015)
The type of care planning evaluated by
Coulter 2015 does not routinely take
place within a primary care consultation
alone but is more likely to be initiated by
a secondary care specialist liaising with
the primary care team. Primary care will
be the focus of our review
Coulter 2015 looked at personalised
care planning, and inclusion crite-
ria for this study capture a subset of
studies evaluating elements of pa-
tient involvement in decision-mak-
ing. Our review criteria are much
broader in terms of studies to facili-
tate patient involvement
-
Interventions
before con-
sultations for
helping pa-
tients address
their informa-
tion needs
(Kinnersley
2008)
Kinnersley 2008 focused on interventions
targeted only at patients, whereas we are
interested in interventions aimed at pa-
tients, practitioners, or both, as well as
any elements of organisational change
Kinnersley 2008 looked at studies of
interventions to support patients in
information-gathering from a doc-
tor or a nurse during a consultation.
Whilst this is an important aspect of
patient involvement, it is only 1 ele-
ment of a complex process. We there-
fore feel that the inclusion criteria
used in this review will have missed
many studies that are of relevance to
our review
-
Interventions
for improving
the adoption
of shared de-
cision-making
by healthcare
professionals
(Légaré 2018)
This review covers an important top-
ic in the research area of shared deci-
sion-making. However, it focuses on-
ly on studies of interventions designed
to improve the healthcare profession-
al’s adoption of shared decision-making
and excludes many studies focusing on
patient-mediated involvement in deci-
sion-making
- -
Interventions
for improving
patients' trust
in doctors and
groups of doc-
tors (Rolfe
2014)
- We know from our own work that
there are associations between pa-
tients’ trust in the doctor and their in-
volvement in decision-making about
their care. Studies of interventions to
promote patient involvement in de-
cision-making would be included by
Rolfe 2014. However, the scope of this
review is very broad, and it does not
-
Table 1.   Comparison of our proposed review with existing systematic reviews of similar interventions  (Continued)
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address our aim: to systematically re-
view studies of interventions that fa-
cilitate patient involvement, focusing
on older people with multi-morbidity
Table 1.   Comparison of our proposed review with existing systematic reviews of similar interventions  (Continued)
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Appendix 1. MEDLINE search strategy
1. exp aged/
2. Aging/
3. (Late life or elder* or aged or old age or geriatric or seniors).ti,ab,kw.
4. ((old or older or aging or aged or senior or elder*) adj3 (person or persons or people or adult* or subject* or patient* or consumer* or
male or males or female* or men or women)).ti,ab,kw.
5. or/1-4
6. "Physician-Patient Relations"/
7. "Professional-Patient Relations"/
8. exp Decision Making/
9. Decision Support Techniques/
10. Decision Support Systems, Clinical/
11. Cooperative Behavior/
12. exp Communication/
13. (consensus or partnership*).ti,ab,kw.
14. ((share or shared or sharing or support* or inform* or making or behavior* or aid*) adj2 (decision* or deciding or choice*)).ti,ab,kw.
15. "Group Processes"/
16. or/6-15
17. exp Patients/
18. caregivers/
19. exp Family/
20. Friends/
21. or/17-20
22. and/16,21
23. exp Community Participation/
24. Stakeholder Participation/
25. exp Patient-Centered Care/
26. ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) adj3 (partner* or participat* or centre* or center* or
communicat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower* or engag* or collab* or
advoca* or organi#ation* or respons* or question* or educat* or inform* or train* or shar* or joint or choice* or preference*)).tw.
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27. or/22-26
28. exp Comorbidity/
29. exp polypharmacy/
30. (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or co-morbid*).ti,ab,kw.
31. ((concomit* or concurren* or multi* or multiple) adj3 (ill* or condition* or morbidit* or syndrom* or disorder* or disease*)).ti,ab,kw.
32. exp Chronic Disease/
33. ((chronic* or elderly or age*) adj3 (disease* or ill* or care or condition? or disorder* or health* or medication* or syndrom* or symptom*
or chronic*)).ti,ab,kw.
34. ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or medica-
tion$ or symptom$ or syndrom$)).ti,ab,kw.
35. or/28-34
36. exp Primary Health Care/
37. General Practice/
38. General Practitioners/
39. exp Home Care Services/
40. physicians, family/
41. Physicians, primary care/
42. Private Practice/
43. "Family Practice"/
44. Community Health Services/
45. Community Health Nursing/
46. Community Pharmacy Services/
47. Community Health Workers/
48. Preventive Health Services/
49. Primary care nursing/
50. Community medicine/
51. Community health centres/
52. Health Promotion/
53. health promotion.ti,ab,kw.
54. ((home* or visit* or preventive* or general or family or primary or community) adj3 (health or practice* or medicine or physician* or
nursing or pharmacy or program* or service* or care)).ti,ab,kw.
55. ((family or primary or general or community) adj2 (pharmacist* or physician* or doctor* or practitioner* or healthcare*)).ti,ab,kw.
56. ((nurse* or nursing) adj2 (practice* or practitioner* or prescriber*)).ti,ab,kw.
57. (GPs or GPSI or GPwSI).ti,ab,kw.
58. or/36-57
59. randomized controlled trial.pt.
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60. controlled clinical trial.pt.
61. randomized.ab.
62. placebo.ab.
63. drug therapy.fs.
64. randomly.ab.
65. trial.ab.
66. groups.ab.
67. or/59-66
68. quasi experimental study/
69. pragmatic clinical trial/
70. or/67-69
71. (animals not (humans and animals)).sh.
72. 70 not 71
73. and/5,27,35,58,72
Appendix 2. The Cochrane Library search strategy
ID Search
#1 MeSH descriptor: [Aged] explode all trees
#2 MeSH descriptor: [Aging] this term only
#3 (Late life or elder* or aged or old age or geriatric or seniors):ti,ab,kw (Word variations have been searched)
#4 ((old or older or aging or aged or senior or elder*) N3 (person or persons or people or adult* or subject* or patient* or consumer* or
male or males or female* or men or women)):ti,ab,kw (Word variations have been searched)
#5 {or #1-#4}
#6 MeSH descriptor: [Physician-Patient Relations] this term only
#7 MeSH descriptor: [Professional-Patient Relations] this term only
#8 MeSH descriptor: [Decision Making] explode all trees
#9 MeSH descriptor: [Decision Support Techniques] this term only
#10 MeSH descriptor: [Decision Support Systems, Clinical] this term only
#11 MeSH descriptor: [Decision Support Systems, Clinical] this term only
#12 MeSH descriptor: [Cooperative Behavior] this term only
#13 MeSH descriptor: [Communication] explode all trees
#14 partnership*:ti,ab,kw (Word variations have been searched)
#15 ((share or shared or sharing or support* or inform* or making or behavior* or aid*) next (decision* or deciding or choice*)):ti,ab,kw
(Word variations have been searched)
#16 {or #6-#15}
#17 MeSH descriptor: [Patients] explode all trees
#18 MeSH descriptor: [Caregivers] explode all trees
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#19 MeSH descriptor: [Family] explode all trees
#20 MeSH descriptor: [Friends] explode all trees
#21 {or #17-#20}
#22 {and #16, #21}
#23 MeSH descriptor: [Community Participation] explode all trees
#24 MeSH descriptor: [Stakeholder Participation] this term only
#25 MeSH descriptor: [Patient-Centered Care] explode all trees
#26 ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) N2 (partner* or participat* or centre* or center*
or communicat* or consult* or decision* or deliberation* or co-design* or involv* or contribut* or role* or empower* or engag* or collab*
or advoca* or organization* or organisation* or respons* or question* or educat* or inform* or train* or shar* or joint or choice* or prefer-
ence*)):ti,ab,kw (Word variations have been searched)
#27 {or #22-#26}
#28 MeSH descriptor: [Comorbidity] explode all trees
#29 (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or co-morbid*):ti,ab,kw (Word variations have
been searched)
#30 MeSH descriptor: [Polypharmacy] explode all trees
#31 ((concomit* or concurren* or multi* or multiple) N3 (ill* or condition* or morbidit* or syndrom* or disorder* or disease*)):ti,ab,kw
(Word variations have been searched)
#32 MeSH descriptor: [Chronic Disease] explode all trees
#33 (chronic* N3 (disease* or ill* or care or condition? or disorder* or health* or medication* or syndrom* or symptom* or chron-
ic*)):ti,ab,kw (Word variations have been searched)
#34 ((coocur* or co-ocur* or coexist* or co-exist* or multipl*) N3 (disease? or ill* or care or condition? or disorder* or health* or medication*
or symptom* or syndrom*)):ti,ab,kw (Word variations have been searched)
#35 {or #28-#34}
#36 MeSH descriptor: [Primary Health Care] explode all trees
#37 MeSH descriptor: [General Practice] this term only
#38 MeSH descriptor: [General Practitioners] this term only
#39 MeSH descriptor: [Home Care Services] explode all trees
#40 MeSH descriptor: [Physicians, Family] this term only
#41 MeSH descriptor: [Physicians, Primary Care] this term only
#42 MeSH descriptor: [Private Practice] this term only
#43 MeSH descriptor: [Family Practice] this term only
#44 MeSH descriptor: [Community Health Services] this term only
#45 MeSH descriptor: [Community Health Nursing] this term only
#46 MeSH descriptor: [Community Pharmacy Services] this term only
#47 MeSH descriptor: [Community Health Workers] this term only
#48 MeSH descriptor: [Preventive Health Services] this term only
#49 MeSH descriptor: [Primary Care Nursing] this term only
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#50 MeSH descriptor: [Community Medicine] this term only
#51 MeSH descriptor: [Community Health Centers] this term only
#52 MeSH descriptor: [Health Promotion] this term only
#53 health promotion:ti,ab,kw (Word variations have been searched)
#54 ((home* or visit* or preventive* or general or family or primary or community) N3 (health or practice or medicine or physician* or
nursing or pharmacy or program* or service* or care)):ti,ab,kw (Word variations have been searched)
#55 ((nurse* or nursing) N2 (practice* or practitioner* or prescriber*)):ti,ab,kw (Word variations have been searched)
#56 (GPs or GPSI or GPwSI):ti,ab,kw (Word variations have been searched)
#57 ((family or primary or general or community) N2 (pharmacist* or physician* or doctor* or practitioner* or healthcare*)):ti,ab,kw (Word
variations have been searched)
#58 {or #36-#57}
#59 {and #5, #27, #35, #58}
Appendix 3. CINAHL search strategy
 
# Query Results
S65 S54 AND S64 3,543
S64 S55 or S56 or S57 or S58 or S59 or S60 or S61 or S62 or S63 Display
S63 TI (singl* or doubl* or tripl* or trebl*) and TI (blind* or mask*) Display
S62 AB (singl* or doubl* or tripl* or trebl*) and AB (blind* or mask*) Display
S61 AB (random* or trial or placebo*) or TI (random* or trial or placebo*) Display
S60 MH Quantitative Studies Display
S59 MH Placebos Display
S58 MH Random Assignment Display
S57 MH Clinical Trials+ Display
S56 PT Clinical Trial Display
S55 "randomi?ed controlled trial" or PT randomized controlled trial Display
S54 S5 AND S27 AND S35 AND S53 22,788
S53 S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47
OR S48 OR S49 OR S50 OR S51 OR S52
789,958
S52 TX (GPs or GPSI or GPwSI) 5,759
S51 TX ((nurse* or nursing) N2 (practice* or practitioner* or prescriber*)) 163,450
S50 TX ((family or primary or general or community) N2 (pharmacist* or physician* or doctor*
or practitioner* or healthcare*))
63,366
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S49 TX ((home* or visit* or preventive* or general or family or primary or community) N3
(health or practice* or medicine or physician* or nursing or pharmacy or program* or ser-
vice* or care))
461,327
S48 TX health promotion 93,464
S47 (MH "Health Promotion+") 41,722
S46 (MH "Community Health Centers+") 3,875
S45 (MH "Community Medicine") 100
S44 "Primary care nursing" 239
S43 "Preventive Health Services" 215
S42 (MH "Community Mental Health Services+") 8,330
S41 (MH "Community Health Nursing+") 24,882
S40 (MH "Community Health Services+") 282,870
S39 (MH "Home Health Care+") 35,210
S38 (MH "Physicians, Family") 10,534
S37 (MH "Family Practice") 13,037
S36 (MH "Primary Health Care") 38,524
S35 S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 260,013
S34 TX ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) N3 (disease? or ill$ or care or
condition? or disorder$ or health$ or medication$ or symptom$ or syndrom$))
219
S33 TX ((chronic* or elderly or age*) N3 (disease* or ill* or care or condition? or disorder* or
health* or medication* or syndrom* or symptom* or chronic*))
207,000
S32 (MH "Chronic Disease") 36,416
S31 TX ((concomit* or concurren* or multi* or multiple) N3 (ill* or condition* or morbidit* or
syndrom* or disorder* or disease*))
17,150
S30 TX (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or
co-morbid*)
51,501
S29 (MH "Polypharmacy") 2,365
S28 (MH "Comorbidity") 30,417
S27 S22 OR S23 OR S24 OR S25 OR S26 660,109
S26 TX ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) N3
(partner* or participat* or centre* or center* or communicat* or consult* or decision*
or deliberation* or co#design* or involv* or contribut* or role* or empower* or engag*
or collab* or advoca* or organi#ation* or respons* or question* or educat* or inform* or
train* or shar* or joint or choice* or preference*))
620,182
  (Continued)
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S25 (MH "Patient Centered Care") 18,385
S24 (MH "Consumer Participation") 12,197
S23 "Community Participation" 882
S22 S16 AND S21 73,996
S21 S17 OR S18 OR S19 OR S20 337,406
S20 "Friends" 9,930
S19 (MH "Family+") 137,904
S18 (MH "Caregivers") 22,491
S17 (MH "Patients+") 196,044
S16 S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 464,650
S15 ((share or shared or sharing or support* or inform* or making or behavior* or aid*) N2
(decision* or deciding or choice*))
94,478
S14 TX consensus or partnership* 47,038
S13 (MH "Group Processes+") 157,942
S12 (MH "Communication+") 166,424
S11 (MH "Cooperative Behavior") 3,769
S10 (MH "Decision Support Systems, Clinical") 2,135
S9 (MH "Decision Support Techniques+") 4,463
S8 (MH "Decision Making+") 72,720
S7 (MH "Professional-Patient Relations+") 63,673
S6 (MH "Physician-Patient Relations") 19,830
S5 S1 OR S2 OR S3 OR S4 811,443
S4 TX ((old or older or aging or aged or senior or elder*) N3 (person or persons or people
or adult* or subject* or patient* or consumer* or male or males or female* or men or
women))
160,270
S3 TX (Late life or elder* or aged or old age or geriatric or seniors) 783,674
S2 (MH "Aging+") 28,816
S1 (MH "Aged+") 434,411
  (Continued)
 
Appendix 4. Embase search strategy
1. aged/
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2. exp aging/
3. (Late life or elder* or aged or old age or geriatric or seniors).ti,ab,kw.
4. ((old or older or aging or aged or senior or elder*) adj3 (person or persons or people or adult* or subject* or patient* or consumer* or
male or males or female* or men or women)).ti,ab,kw.
5. or/1-4
6. doctor patient relation/
7. professional-patient relationship/
8. decision making/
9. exp decision support system/
10. clinical decision support system/
11. exp cooperation/
12. exp interpersonal communication/
13. (partnership* or consensus).ti,ab,kw.
14. ((share or shared or sharing or support* or inform* or making or behavior* or aid*) adj2 (decision* or deciding or choice*)).ti,ab,kw.
15. exp group process/
16. or/6-15
17. exp patient/
18. caregiver/
19. exp family/
20. friend/
21. or/17-20
22. and/16,21
23. community participation/
24. stakeholder engagement/
25. exp patient care/
26. ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) adj3 (partner* or participat* or centre* or center* or
communicat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower* or engag* or collab* or
advoca* or organi#ation* or respons* or question* or educat* or inform* or train* or shar* or joint or choice* or preference*)).tw.
27. or/22-26
28. comorbidity/ or comorbidity assessment/
29. polypharmacy/
30. (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or co-morbid*).ti,ab,kw.
31. ((concomit* or concurren* or multi* or multiple) adj3 (ill* or condition* or morbidit* or syndrom* or disorder* or disease*)).ti,ab,kw.
32. exp chronic disease/
33. ((chronic* or elderly or age*) adj3 (disease* or ill* or care or condition? or disorder* or health* or medication* or syndrom* or symptom*
or chronic*)).ti,ab,kw.
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34. ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or medica-
tion$ or symptom$ or syndrom$)).ti,ab,kw.
35. or/28-34
36. exp primary health care/
37. exp general practice/
38. general practitioner/
39. exp home care/
40. private practice/
41. community care/
42. general practice/
43. exp community health nursing/
44. pharmacy/
45. health auxiliary/
46. exp preventive health service/
47. community medicine/
48. health center/
49. exp health promotion/
50. health promotion.ti,ab,kw.
51. ((home* or visit* or preventive* or general or family or primary or community) adj3 (health or practice* or medicine or physician* or
nursing or pharmacy or program* or service* or care)).ti,ab,kw.
52. ((family or primary or general or community) adj2 (pharmacist* or physician* or doctor* or practitioner* or healthcare*)).ti,ab,kw.
53. ((nurse* or nursing) adj2 (practice* or practitioner* or prescriber*)).ti,ab,kw.
54. (GPs or GPSI or GPwSI).ti,ab,kw.
55. or/36-54
56. randomized controlled trial/
57. controlled clinical trial/
58. single blind procedure/ or double blind procedure/
59. crossover procedure/
60. random*.tw.
61. placebo*.tw.
62. ((singl* or doubl*) adj (blind* or mask*)).tw.
63. (crossover or cross over or factorial* or latin square).tw.
64. (assign* or allocat* or volunteer*).tw.
65. or/56-64
66. and/5,27,35,55,65
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Appendix 5. ProQuest Dissertations search strategy
(noft(((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) NEAR (partner* or participat* or centre* or center*
or communicat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower* or engag* or collab*
or advoca* or organi#ation* or respons* or question* or educat* or inform* or train* or shar* or joint or choice* or preference*))) AND
noft((comorbidity or (chronic* or elderly or age*) NEAR (disease* or ill* or care or condition? or disorder* or health* or medication* or
syndrom* or symptom* or chronic*))) AND noft(((primary or community) NEAR (health or care)))) AND noQ((old or older or aging or aged
or senior or elder*) NEAR (person or persons or people or adult* or subject* or patient* or consumer* or male or males or female* or men
or women))
Appendix 6. PsycINFO search strategy
1. exp aging/
2. (Late life or elder* or aged or old age or geriatric or seniors).ti,ab.
3. ((old or older or aging or aged or senior or elder*) adj3 (person or persons or people or adult* or subject* or patient* or consumer* or
male or males or female* or men or women)).ti,ab.
4. or/1-3
5. exp decision making/
6. decision support systems/
7. cooperation/
8. exp communication/
9. (consensus or partnership*).ti,ab.
10. ((share or shared or sharing or support* or inform* or making or behavior* or aid*) adj2 (decision* or deciding or choice*)).ti,ab.
11. exp group dynamics/
12. or/5-11
13. exp patients/
14. caregivers/
15. exp family/
16. social support/
17. or/13-16
18. and/12,17
19. community involvement/
20. ((patient* or consumer* or user* or carer* or caregiver* or client* or famil* or lay* or stakeholder*) adj3 (partner* or participat* or
centre* or center* or communicat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower*
or engag* or collab* or advoca* or organi#ation* or respons* or question* or educat* or inform* or train* or shar* or joint or choice* or
preference*)).tw.
21. or/18-20
22. comorbidity/
23. polypharmacy/
24. (multidisease* or multi-disease* or multimorbidit* or comorbid* or multi-morbidit* or co-morbid*).ti,ab.
25. ((concomit* or concurren* or multi* or multiple) adj3 (ill* or condition* or morbidit* or syndrom* or disorder* or disease*)).ti,ab.
26. exp chronic illness/ or "chronicity (disorders)"/
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27. ((chronic* or elderly or age*) adj3 (disease* or ill* or care or condition? or disorder* or health* or medication* or syndrom* or symptom*
or chronic*)).ti,ab.
28. ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or medica-
tion$ or symptom$ or syndrom$)).ti,ab.
29. or/22-28
30. primary health care/
31. general practitioners/
32. general practitioners/
33. home care/
34. private practice/
35. family physicians/
36. exp Community Services/
37. exp Community Health/
38. primary health care/
39. Health Care Delivery/
40. health promotion/
41. health promotion.ti,ab.
42. ((home* or visit* or preventive* or general or family or primary or community) adj3 (health or practice* or medicine or physician* or
nursing or pharmacy or program* or service* or care)).ti,ab.
43. ((family or primary or general or community) adj2 (pharmacist* or physician* or doctor* or practitioner* or healthcare*)).ti,ab.
44. ((nurse* or nursing) adj2 (practice* or practitioner* or prescriber*)).ti,ab.
45. (GPs or GPSI or GPwSI).ti,ab.
46. or/30-45
47. random*.ti,ab,hw,id.
48. intervention.ti,ab,hw,id.
49. trial.ti,ab,hw,id.
50. placebo*.ti,ab,hw,id.
51. groups.ab.
52. ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).ti,ab,hw,id.
53. (cross over or crossover).ti,ab,hw,id.
54. latin square.ti,ab,hw,id.
55. (assign* or allocat* or volunteer*).ti,ab,hw,id.
56. (control or controlled).ti,ab,hw,id.
57. treatment effectiveness evaluation/
58. mental health program evaluation/
59. exp experimental design/
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60. "2100".md.
61. or/47-60
62. animal.po.
63. 61 not 62
64. and/4,21,29,46,63
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Changes to proposed outcome categories
At the time of writing the proposal, the review authors were not able to predict every outcome measure that might be reported by included
studies. It was therefore necessary to make some minor adjustments to our proposed categories to capture the extracted data accurately.
Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
74
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
• The ‘patient evaluation of care’ category was extended to include patients’ evaluations of the intervention being delivered (‘patient
evaluation of care/the intervention’).
• The category ‘quality of care’ was added as it was felt that this outcome was not adequately captured by the earlier categories.
• When extracting data, the review authors noticed that the majority of measures falling into the ‘physical health status’ category were
also relevant to the ‘psychological and psychosocial health status’ category; therefore, these two original categories were combined
to become ‘health status’.
• Several measures that fitted the ‘knowledge and skills’ category could also be placed in the ‘health behaviours’ category. The pre-
defined ‘knowledge and skills’ category was therefore broadened by combining these categories, and the new category was renamed
‘patient engagement and enablement’.
• The category 'organisational change as a result of evaluation of the intervention' was removed as the review authors considered this
to be less applicable to the types of included studies (RCTs, quasi-RCTs) and better suited to action research methods.
• The category 'healthcare use and costs' was broadened to include costs to patients and society.
Thus the main outcomes for the ‘Summary of findings’ table became (1) evidence of patient involvement in decision-making; (2) health
status; (3) patient engagement and enablement; (4) patient evaluation of care/the intervention; (5) practitioners’ knowledge and skills;
(6) resource use and cost; and (7) adverse outcomes (patient, practitioner, or observer perceptions of less patient involvement in deci-
sion-making than before the intervention).
Changes to proposed method of managing multiple outcomes assigned to the same category
As originally outlined in the proposal, two review authors independently assigned the outcomes reported in each included study to the
review’s outcome categories. Frequently, more than one outcome measure was assigned to each category per included study. To ensure
that the review remained relevant to clinicians, researchers, and policy makers, the process for managing this scenario was adapted slight-
ly from the protocol. This decision was made based on the review authors’ concerns that the outcome with the median effect estimate
might not always be the outcome of most relevance to patients, or from a primary care perspective. These concerns arose because of the
apparent clinical and methodological heterogeneity of the included studies and the variety of outcomes measured. Therefore, the review
authors:
• prioritised outcomes reported in published papers to date (additional criteria since publication of protocol);
• selected the primary outcome as reported by study authors;
• when no primary outcome was identified, selected the outcome specified in the sample size calculation;
• when there were no sample size calculations, selected the outcome that appeared to relate most closely to the primary outcome of the
review (additional criteria since publication of the protocol);
• when outcomes did not directly relate to the primary outcome, selected the patient-reported measure, and if no patient-reported
measure was available, selected the measure most relevant to primary care (additional criteria since publication of protocol); and
• if all of the above were not appropriate, ranked the effect estimates and selected the outcome with the median effect estimate.
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